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Anthelmintics are commonly used by livestock producers. Parasite resistance has been 
reported in ruminants in multiple macrocyclic lactones, after their use over time. As new 
versions of anthelmintics are released to the market, evaluations for resistance need to be 
conducted. In addition, the use of anthelmintics has also been reported to be beneficial at 
reducing negative impacts of fescue toxicity. Previous work has shown improvements in growth 
performance of growing animals when treated with either ivermectin or extended-release 
eprinomectin. No work has determined the mechanism for this improvement though. The 
objective of this thesis was to determine if parasite resistance to extended-release eprinomectin 
was present on a cow-calf operation after three years of use and to explore CYP450 activity and 
liver function as potential mechanism for extended-release eprinomectin to mitigate fescue 
toxicity in fall-born beef heifers grazing endophyte-infected tall fescue.  
Only one extended-release anthelmintic is currently on the market for ruminants and only 
limited data exist relative to parasite resistance. Therefore, the objective of this experiment was 
to determine if parasite resistance to extended-release eprinomectin (LongRange) was present in 
an operation with 3 yr of prior eprinomectin use and impacts on heifer growth performance. Fall-
born Angus × Simmental heifers (224 ± 22 d of age) were randomly assigned 1 of 3 treatments: 
extended-release eprinomectin (ERE), extended-release eprinomectin and oxfendazole 
(COMBO), or saline control (CON). Control cattle had greater FEC from d 55 to 83 compared 
to ERE and COMBO heifers, although FEC was not different any other time point. Fecal egg 
count reduction (FERT) for ERE and COMBO were above the 90% threshold (91% and 98% 
reduction, respectively). Packed cell volume was similar between treatments throughout the 
experiment. Treated cattle had greater BW and BCS beginning on d 83 and 55, respectively. 
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Parasite resistance to extended-release eprinomectin was not present based on FERT, and treated 
heifers had greater growth performance compared to CON heifers.  
The mechanism causing increased growth performance of growing cattle treated with 
extended-release eprinomectin has not been determined. Therefore, the objective of this 
experiment was to evaluate CYP450 and liver enzymes as potential mechanisms of extended-
release eprinomectin mitigating fescue toxicosis in beef heifers grazing endophyte-infected tall 
fescue. Fall-born Angus × Simmental heifers (42 heifers; 170.2 ± 20.0 kg initial body weight 
(BW); 222 ± 21 d of age) were stratified by d -2 fecal egg count and BW and were assigned to 
one of six groups (7 heifers per group) using a stratified randomized design. Groups were then 
assigned to one of two treatments: extended-release eprinomectin (ERE; n = 3), or saline control 
(CON; n= 3). Body weight and BCS was improved in ERE heifers beginning on d 112 and 28 
respectively. Respiration rates tended to be improved and HCS was improved in ERE heifers on 
d 55 and 83. Serum prolactin and total urinary ergot alkaloids were similar between treatments. 
In addition, ERE cattle tended to have greater total CYP3A4 activity. Liver enzymes including 
alkaline phosphatase and gamma-glutamyl transferase were greater in ERE heifers and total 
protein tended to be greater than control. Extended-release eprinomectin improved heifer growth 
performance, HCS, and tended to improve RR. In addition, extended-release eprinomectin 
tended to increase total CYP450 activity, and also had greater levels of several liver enzymes in 
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 Tall fescue (Festuca arundinacea) is a common forage that beef cattle in the United 
States graze. An issue caused by tall fescue is reduced performance and physiological conditions 
of beef cattle also known as fescue toxicosis. Many strategies have been evaluated to mitigate 
this condition while grazing endophyte-infected tall fescue, but none have completely solved the 
issue. Different variates of tall fescue including endophyte-free and novel endophyte tall fescue 
do not cause issues of fescue toxicosis. Although, these options are not feasible due to poor 
persistence and are expensive to reseed. Anthelmintics are commonly used in the beef industry to 
treat parasite infections and may be an option at reducing symptoms of fescue toxicosis, although 
the mechanism is not understood. However, with use of anthelmintics, parasite resistance 
becomes a concern. As new anthelmintics reach the market, research needs to be conducted to 
determine when resistance becomes an issue.  
TALL FESCUE 
 Tall fescue (Festuca arundinacea) is a cool-season perennial grass that covers 14 million 
hectares in the United States and is persistent and productive in multiple environments 
(Thompson et al., 2001). The agronomic characteristics of tall fescue make it an ideal candidate 
for pastures as it can withstand drought, poor soil conditions, and intense grazing (Gunter and 
Beck, 2004; Kallenbach, 2015). In the United States, approximately 12 million beef cows graze 
tall fescue (Kallenbach, 2015). Tall fescue has these ideal attributes because of the endophyte 




Endophyte and Ergot Alkaloids 
 The toxic endophyte Neotyphodium coenophialum was first reported by Bacon et al. 
(1977). The toxic endophyte is located in the intracellular spaces of sheath, stem, leaf, and seed 
of the plant but it does not invade the cells of the plant or become pathogenic (Thompson et al., 
2001). The fungus and the plant have a symbiotic relationship in which both benefit from the 
relationship (Arachevaleta et al., 1989; Porter et al., 1994). The toxic fungus deters ruminants 
and insects from feeding on it and negatively affecting the animal’s growth and reproduction 
(Siegel et al., 1990; Porter et al., 1994; Thompson et al., 2001). The toxic fungus also improves 
the drought tolerance of the plant (Siegel et al., 1990; Porter et al., 1994; Thompson et al., 2001). 
In exchange, the fungus is provided with protection, nutrients, reproduction and dissemination 
from the plant (Arachevaleta et al., 1989; Thompson et al., 2001).  
Three classes of alkaloids are produced from the toxic endophyte: pyrrolizidine, 
peramine, and ergot alkaloids (Siegel et al., 1990). Of the three classes produced, ergot alkaloids 
are the only endophyte-derived alkaloid that deters ruminants from grazing as it is a mycotoxin 
to mammals (Strickland et al., 2011). Ergot alkaloids produce many different ergopeptines and 
the ergopeptine in highest concentration is ergovaline (Lyons et al., 1986; Strickland et al., 
2011). The ergoline ring structure is similar to that of dopamine, norepinephrine, and 
epinephrine; which is likely the reason why ergot alkaloids can affect animals (Berde, 1980; 
Weber, 1980).  
Fescue Toxicosis and Animal Performance 
Fescue toxicosis is of great concern to producers with cattle grazing endophyte-infected 
tall fescue as cattle that graze tall fescue tend to have an unthrifty appearance and poor animal 
performance during the summer months (Schmidt and Osborn, 1993). Symptoms of fescue 
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toxicosis include decreased weight gain, decreased feed intake, increased vasoconstriction, rough 
hair coat, elevated body temperature, labored breathing, decreased serum prolactin levels and 
poor reproductive performance (Schmidt and Osborn, 1993; Paterson et al., 1995; Strickland et 
al., 2011; Aiken and Strickland, 2013).  
Previous literature has strongly supported the association of fescue toxicosis with 
decreased weight gain and feed intake in cattle consuming ergot alkaloids. Schmidt and Osborn 
(1993) stated that a portion of the reduced weight gain in cattle grazing endophyte-infected (E+) 
tall fescue is an outcome from decreased feed intake; however, it could partially also be impacted 
by environmental temperature as well (Peters et al., 1992). Cattle grazing E+ tall fescue have 
been known to graze less time during the day, as they would spend their days in the shade or in 
bodies of water, and graze mostly at night (Bond et al., 1984). Most of the research focused on 
animal performance and E+ tall fescue was in beef steers grazing in the summer. Paterson et al. 
(1995) compiled data from multiple studies and concluded that steers grazing E+ tall fescue had 
decreased weight gain compared to steers grazing endophyte-free (E-) tall fescue despite 
multiple locations and management styles of the experiments.  Additionally, for every 10% 
increase in endophyte infestation, average daily gain (ADG) was predicted to decrease by 0.045 
kg per d (Paterson et al., 1995).  
Less data is available for cows grazing E+ tall fescue compared to E- tall fescue; 
nonetheless, from the data available, it was concluded that cows grazing E+ tall fescue lost more 
weight compared to E- cows (Schmidt and Osborn, 1993; Paterson et al., 1995). Furthermore, 
these cows also had decreased pregnancy rates and milk production, as well as, weaning lighter 
weight calves. Schmidt et al. (1986) reported a large magnitude difference between pregnancy 
rates of heifers grazing E+ tall fescue to E- tall fescue (55% vs. 96%, respectively). When those 
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same animals were rebred as primiparous cows, only 33% of those grazing E+ were pregnant 
compared to the 93% of those grazing E- (Schmidt et al., 1986). Also, Boling (1985) and Gay et 
al. (1988) both reported reduced calving rates in cows grazing E+ compared to those grazing E- 
(67% vs 86% and 55% and 95%, respectively). Paterson et al. (1995) noted that the decreased 
conception rates could partially be related to the negative impact of the E+ fescue on cow weight 
loss and body condition compared to E- fescue. When comparing heifers and cows, Thompson et 
al. (2001) noted that beef heifers experienced a larger negative impact on reproduction than 
cows. Strickland et al. (2011) discussed the impacts of ergot alkaloids on heifer follicular 
development and concluded that there is a minimal direct effect; however, it could be escalated 
by an increased ambient temperature.  
The similar ring structure of ergot alkaloids to biogenic amines, dopamine, 
norepinephrine and epinephrine allows ergot alkaloids to bind to biogenic amine receptors and 
elicit effects of decreased serum prolactin and vasoconstriction (Strickland et al., 2011).  
Unfortunately, prolactin is highly variable from animal to animal and can differ based on 
physiological factors of the animal in addition to environmental factors such as day length, 
season, and temperature (Hill et al., 2000). Although in previous research, serum prolactin has 
been most commonly used to determine if animals are exposed to fescue toxicity (Hill et al., 
2000). It is important to note, that prolactin and animal weight gain are not highly correlated. 
However, circulating levels of prolactin indicate ergopeptide affects the dopamine receptors 
(Bacon and Hill, 2013).  
Vasoconstriction is another symptom of fescue toxicosis and occurs as the vascular tone 
contracts and restricts blood flow to many tissues (Rhodes et al., 1991; Aiken et al., 2009; 
Strickland et al., 2011). Reduced blood flow affects the animal’s ability to dissipate heat and 
5 
 
hinders the reproduction of the animal (Rhodes et al., 1991; Aiken et al., 2009; Strickland et al., 
2011). With the inability to dissipate heat, cattle grazing endophyte-infected tall fescue will also 
have increased respiration as a mode to attempt to dissipate heat (Finch, 1986). In addition, 
hematocrit measures the animal’s oxygen carrying capacity of the circulatory system and level of 
dehydration (Nordenson, 2006). Hematocrit can also be impacted after chronic ergot alkaloid 
exposure (Nordenson, 2006). However, previous research has shown inconclusive results on 
hematocrit values after exposure to ergot alkaloid exposure indicating more research is needed 
(Boling et al., 1989; Bacon and Hill, 2013; Poole et al., 2018). It is also important to note, one 
report indicated that hematocrit was impacted greater by temperature rather than E+ which 
indicates hematocrit may be a better indicator for heat stress than fescue toxicosis (Aldrich et al., 
1993a).  In addition to other symptoms of fescue toxicosis, cattle tend to have a rough hair coat 
when grazing tall fescue as a result of the combination of reduced serum prolactin concentration 
and vasoconstriction (Porter and Thompson Jr, 1992).  
Research is lacking on the metabolism of ergot alkaloids in cattle; however, they are 
assumed to be biotransformed in the liver and may induce liver enzymes (Oliver, 1997; 
Strickland et al., 2011). Additionally, Oliver (1997) summarized previous fescue experiments 
and reported reduced levels of liver serum enzymes in cattle grazing E+ such as alkaline 
phosphatase, alanine transaminase, lipase, aspartate transaminase, and lactic acid dehydrogenase. 
No reports have determined the mechanism that causes the decrease in these serum enzymes 
(Oliver, 1997). Ergot alkaloids are alpha-2 adrenergic receptor agonists and in a review, Oliver 
(1997) hypothesized that this may be impacting some liver enzyme function differences. Alpha-2 
receptor agonists in the liver inhibit adenyl cyclase levels and decreases overall liver function by 
reducing c-AMP regulated liver metabolism (Hems and Whitton, 1980; Jard et al., 1981; Stiles et 
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al., 1984). Additionally, alpha-2 adrenergic receptors agonists can cause reduced rumen 
contractions and feed intake in goats and sheep (Van Miert and Van Duin, 1991; Aldrich et al., 
1993b). Alpha-2 adrenergic receptors are also present on blood vessels and can cause 
vasoconstriction when ergot alkaloids are present (Jie et al., 1987; Roquebert and Grenie, 1987; 
Badia et al., 1988). Although the exact mechanism is unknown, it is hypothesized that this is 
reducing animal performance when grazing E+ (Oliver, 1997).  
Blood metabolites such as serum cholesterol, total protein, triglyceride, and blood urea 
nitrogen levels have also been reported to be decreased in cattle grazing E+ (Bond et al., 1984; 
Thompson and Stuedemann, 1993; Oliver, 1997). Suppressed levels of cholesterol and total 
protein are suggested to be related to reduced feed intake when the animals are experiencing heat 
stress (Martin and Edwards, 1986). In addition, reduced serum triglyceride levels is hypothesized 
to be associated with an increase in alpha-2 adrenergic receptor activity (Oliver, 1997). Reduced 
blood urea nitrogen levels was proposed to be due to mild dehydration of cattle grazing E+ 
(Oliver, 1997).  
Ergot alkaloid levels can be measured in the urine after an animal has been exposed to the 
toxic endophyte as another measurement to determine the level of exposure. Stuedemann et al. 
(1998) reported that 96% of ergot alkaloids are excreted in the urine. Hill et al. (2000) compared 
serum prolactin concentrations and urinary alkaloid excretions from the same animals at the 
same time points to determine which is a better indicator of toxicity. In the experiment, Hill et al. 
(2000) noted that compared to serum prolactin concentrations, urinary alkaloid excretions were 
consistently at greater levels for cattle grazing E+ under different experimental conditions. Also, 
when switching from E+ to E- or E- to E+, urinary alkaloids was a more accurate assessment of 
fescue toxicity exposure than serum prolactin concentrations (Hill et al., 2000). Although urinary 
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alkaloids are not a commonly used indicator of fescue toxicosis.  Additionally, Hill et al. (2000) 
described a relationship between animal performance and urinary alkaloid excretion; however, 
more research is needed to determine if this is applicable for multiple experiments.  
Impact on the Beef Industry 
Fescue toxicosis has a significant impact on the beef industry as over 12 million beef 
cows consume tall fescue (Kallenbach, 2015). Reduced reproductive efficiency and decreased 
weaning weights are the greatest economic impact on the beef industry related to fescue toxicosis 
(Porter and Thompson Jr, 1992) costing the industry close to $2 billion annually (Kallenbach, 
2015). Reproduction issues such as failure to conceive or early embryonic loss due to fescue 
toxicosis is to blame for $1.5 billion annually (Hoveland, 1993; Kallenbach, 2015). Additionally, 
decreased weaning weights of calves grazing tall fescue with their dams is associated with the 
other $500 million in losses that the beef industry faces each year. Impacts on the stocker 
industry are difficult to quantify, as most stocker operations avoid grazing cattle on tall fescue 
because of the reduced performance (Hoveland, 1993).  
Mitigation Strategies 
 Tall fescue is included in many grazing systems across the United States, and with the 
concern of fescue toxicosis, multiple strategies to mitigate symptoms have been researched. 
Diluting E+ tall fescue pastures with clover or another plant species is an option. However, 
Kallenbach (2015) acknowledged that although interseeding clover would add nutritional value 
to the pasture, it would not necessarily prevent fescue toxicosis. The increases in animal 
performance were similar between pastures with clover added to toxic and nontoxic tall fescue, 
indicating that the clover may only mask the toxicosis effects and not eliminate the problem 
(Roberts and Andrae, 2004; Aiken and Strickland, 2013). In the same manner, cattle grazing E+ 
8 
 
tall fescue can be supplemented to dilute the intake of the endophyte; however, this has similar 
results to interseeding clover and will not eliminate the problem (Roberts and Andrae, 2004; 
Kallenbach, 2015).  
The most toxic part of the tall fescue plant is the seed head, with ergot alkaloid 
concentrations being three to six times greater than the leaf blades or stems (Rottinghaus et al., 
1991). Seed heads can be suppressed and pasture nutritive value and animal performance can be 
increased; but research shows that forage growth is diminished which impacts the practicality 
and stocking rates of the pastures (Aiken and Strickland, 2013; Kallenbach, 2015). In order to 
prevent fescue toxicosis, the cause of the toxicity needs to be removed: the endophyte. 
Endophyte-free tall fescue may decrease signs of fescue toxicosis, but decreased plant 
persistence limits this approach (Bouton et al., 2002; Aiken and Strickland, 2013; Kallenbach, 
2015). Novel tall fescue (NE) contains a non-toxic endophyte that produces none to very small 
amounts of ergot alkaloids allowing the plant to still have persistence without negatively 
impacting the animal (Gunter and Beck, 2004). Aiken and Strickland (2013) noted that NE 
pastures are costly to establish and do require good grazing management to maintain the 
pastures. Strickland et al. (2011) noted that current management approaches are also looking into 
other mechanisms for mitigating symptoms of fescue toxicosis. 
ANTHELMINTIC AND TALL FESCUE RESEARCH 
 Previous research has focused on the impact of management strategies that livestock 
producers often include on their farms already, such as the use of pharmaceuticals (Strickland et 
al., 2011). One area of pharmaceuticals that has been of interest to some researchers is the use of 
anthelmintic drugs. According to USDA (2015), anthelmintic drugs are those classified as 
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removing parasitic internal worms from the host. These anthelmintic drugs are categorized into 
groups based on their mode of action.  
Classes of Anthelmintic Drugs 
For cattle, there are currently three major classes of anthelmintics: imidazothiazoles, 
benzimidazoles, and macrocyclic lactones (Edmonds et al., 2010). Macrocyclic lactones are 
subdivided into two categories: first-generation avermectins and second-generation milbemycins. 
Each class of anthelmintics has multiple different drugs. An example of imidazothiazoles is 
Lavmisole (Edmonds et al., 2010; USDA, 2015). Benzimidazoles include albendazole, 
fenbendazole and oxfendazole (Edmonds et al., 2010; USDA, 2015). First-generation 
macrocyclic lactones include ivermectin, doramectin, eprinomectin, and abamectin, while an 
example of second-generation macrocyclic lactones is moxidectin (Edmonds et al., 2010; USDA, 
2015).  
Impacts of Internal Parasites on Beef Cattle 
 The most common internal parasite affecting the beef industry are gastrointestinal 
nematode (GIN) parasites (Williams and Loyacano, 2001). A survey conducted by the USDA 
National Health Monitoring System indicated that cow-calf producers consider GIN to be a 
major issue (Stromberg et al., 2015) with $2.5 billion being spent on anthelmintic drugs each 
year (Williams and Loyacano, 2001). Internal parasites can impact cattle of all ages, but younger 
cattle are more susceptible than cows (Miller, 1993). Mature cattle tend to have fewer issues with 
GIN as cattle typically develop an immunity to GIN during their second grazing season, which 
allows them to have minimal need for GIN control (McArthur and Reinemeyer, 2014). Previous 
research has shown that treated calves have improved weaning weights compared to untreated 
calves in spring-calving systems (DeRouen et al., 2009; Stromberg et al., 2015). Additionally, in 
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stocker cattle, improved ADG has been documented in treated vs untreated calves by up to 0.272 
kg difference. Moreover, in cows, improved reproductive performance has been reported 
(Stromberg et al., 2015). Although, previous research has also demonstrated no differences in 
conception rates between heifers treated with ivermectin or untreated controls (Zajac et al., 
1991).  In addition to improvements from internal parasites, anthelmintics can impact external 
parasites on beef cattle as well.   
Impacts of External Parasites on Beef Cattle 
 The horn fly, Haematobia irritans (L.), is one of the most economically harmful pests to 
beef cattle throughout the United States (Byford et al., 1992). In a review conducted by 
Drummond et al. (1981), losses due to horn flies was approximately $730.3 million per year 
which was the largest loss among others including stable flies, ticks, lice, face flies, mosquitoes, 
and mites. Kunz et al. (1991) reported this number to rise to $876 million per year just 10 years 
later. Today, this number has increased to greater than $1 billion annually (Talley, 2018). Costly 
losses to beef cattle from horn flies are associated with reductions in weight gains, feed 
efficiency, and milk production (Campbell, 1976; Byford et al., 1992). Decreases in cattle 
performance are from blood loss along with the stress and annoyance of the flies (Campbell, 
1976; Byford et al., 1992). A threshold of 100 horn flies per side of the animal was defined as 
being economically advantageous to intervene with fly control (Foil and Hogsette, 1994). 
Previous research has also shown that partial herd treatment for horn fly control can be adequate 
to avoid negative consequences of horn flies (Harvey and Brethour, 1981; Harvey and Brethour, 
1983). Although internal and external parasite control was a valuable component of 




Ivermectin and Fescue Toxicosis 
 When ivermectin was first released on the market, many producers added it to their herd 
management plan because of the improved cattle performance (Gasbarre et al., 2009). 
Observational improvements were noted from anthelmintics beyond parasite control; however, 
Ellis et al. (1989) first documented improvements in steer weight gain of ivermectin steers 
compared to untreated controls when grazing E+ tall fescue. Unfortunately, parasite load was not 
monitored, so it is difficult to determine if parasite differences were impacting weight gain (Ellis 
et al., 1989).  
 Crawford Jr et al. (1990) focused on the impacts of injectable ivermectin, administered 
every 2 weeks, in steers without parasites and consumed either E+ hay or E- hay. Improvements 
in ADG were reported in steers fed E + hay when treated with ivermectin compared to steers not 
receiving ivermectin (Crawford Jr et al., 1990). However, no improvements in ADG were noted 
in steers fed E- hay and treated with ivermectin (Crawford Jr et al., 1990).  
Another experiment focused on E+ tall fescue impact on cattle with or without corn 
gluten feed (CGF) supplementation and with or without ivermectin injections over 117 d 
(Crawford and Garner, 1991). All steers were treated with an anthelmintic, ivermectin, at trial 
initiation, but only half in each group received ivermectin injections every two weeks for the 
remainder of the experiment. Increasing supplementation levels were also used to determine if a 
specific threshold of supplementation had improved performance compared to others. 
Unfortunately, fecal egg counts (FEC) were not monitored throughout the experiment. However, 
it was expected that FEC would be low at least for the first 28 d since all cattle were treated with 
ivermectin initially.  All steers that were treated with ivermectin every 2 weeks had improved 
ADG compared to steers not treated every 2 weeks with ivermectin, regardless of the level of 
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supplementation. Neither of the treatments alone were able to have weight gains similar to 
expected gains of cattle grazing E-, not experiencing fescue toxicosis; however, cattle 
supplemented with 8 lbs CGF plus treated every two weeks with ivermectin had similar gains to 
that of cattle on E- tall fescue (Crawford and Garner, 1991).  
The first most notably known data published with FEC reported on cattle grazing E+ and 
treated with or without ivermectin was by Bransby et al. (1993). Bransby et al. (1993) reported a 
large improvement in cattle performance when using ivermectin and grazing E+ tall fescue 
compared to untreated cattle grazing E+ tall fescue. This experiment was conducted over two 
years with the first year having large FEC differences between treatments [120 eggs per gram 
(EPG) and 5 EPG for control and ivermectin treatments, respectively] but the second year had 
smaller differences between FEC (55 EPG and 14 EPG for control and ivermectin treatments, 
respectively).  
In the second part of Bransby et al. (1993), another experiment was conducted comparing 
cattle grazing E + and E -, in addition to anthelmintic treatments of ivermectin, fenbendazole, 
and untreated controls administered on d 0 and 56 d later. In this experiment, parasite level was 
similar between all treatments ranging from 6 EPG to 39 EPG. Cattle treated with ivermectin had 
similar ADG between E+ and E-. Conversely, ivermectin cattle had improved ADG compared to 
untreated controls grazing both E+ and E- as well as cattle grazing E+ treated with fenbendazole. 
Although, cattle treated with fenbendazole grazing E- had the greatest ADG. The authors noted 
that visual symptoms of fescue toxicosis were decreased for ivermectin treated cattle; however, 
parameters utilized were not reported (Bransby et al., 1993). As these cattle had a low parasite 
load already, these results indicated that some of the improved performance could potentially be 
related to ivermectin mitigating fescue toxicosis, which led to more research in this area.  
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In a similar design, Ivy et al. (1993) compared ADG of cattle grazing E+ and E- tall 
fescue and three anthelmintic treatments of ivermectin, fenbendazole, or no treatment. 
Treatments were administered every 28 d of the experiment and FEC were noted to be below the 
economic threshold of 200 EPG (Ivy et al., 1993). No differences were reported between the 
three anthelmintic treatments on E- pastures. However, on E+ pastures ivermectin treated cattle 
had greater ADG compared to the other two anthelmintic treatments (Ivy et al., 1993). 
Unfortunately, no other parameters were reported from this experiment.  
As research was lacking in this area, another experiment was conducted to determine if 
anthelmintic treatment and implanting cattle grazing E+ or E- had marked improvement 
(Bransby et al., 1995). Results from this experiment did not see marked improvement from 
ivermectin alone, but when the combination of the implant and ivermectin treated cattle was used 
on E+ pastures, cattle had improved performance (Bransby et al., 1995). Additionally, the 
combination of the implant and ivermectin and cattle grazing E+ was reported to be similar to all 
treatments grazing E-. Unfortunately, FEC were not reported so parasite differences are 
unknown. An indicator of fescue toxicosis, hair coat score (HCS), was reported to be improved 
in cattle grazing E- compared to cattle grazing E+ and improved in cattle treated with ivermectin, 
although data was not reported.  
As previous research had varying levels of FEC differences, Rosenkrans et al. (2001) 
conducted an experiment of confined cattle consuming E+ hay to determine impacts of 
ivermectin and an immune challenge on cattle performance. Prior to experiment initiation, all 
cattle were administered a double dose of fenbendazole at two time points 10 d apart. This was 
done to ensure cattle did not have high parasite loads. The authors noted that steers were free of 
internal parasites, although FEC data were not reported (Rosenkrans et al., 2001). The day after 
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the last treatment of fenbendazole, cattle were assigned to treatment of a slow-release ivermectin 
bolus or no additional treatment. Over the 28 d period, there was no difference in ADG between 
treatments. Hematocrit (% packed cell volume) was increased in ivermectin treated steers at d 
28. It is important to note that these cattle were not grazing pasture and the experiment was a 
short duration experiment, only 28 d. Most of the previous reports for improvement in ADG was 
reported over a longer grazing period. Overall, these studies indicated that cattle administered an 
anthelmintic, specifically ivermectin, could have fewer reduced symptoms of fescue toxicosis, 
and primarily focused on performance.  
Little research has been conducted on another anthelmintic in the same class as 
ivermectin, eprinomectin, to determine if it would have similar results on cattle grazing E+. 
Gunter et al. (2006) conducted an experiment to determine the effects of a topical eprinomectin 
on fescue toxicosis compared to fenbendazole or untreated cattle when grazing E+ pastures. 
Results from this experiment only saw improved performance of treated cattle compared to 
untreated with no added improvement for the eprinomectin treatment (Gunter et al., 2006). 
Although, there were significant differences in FEC between treatments, which makes it difficult 
to compare growth differences between fescue toxicity and parasite burden. Moreover, indicators 
of fescue toxicosis were not measured. Additionally, this was only one experiment using 
eprinomectin.  Therefore, more research is needed before the impacts of relief to fescue toxicosis 
anthelmintics in the macrocyclic lactone class could provide to the industry is determined.  
EXTENDED-RELEASE EPRINOMECTIN 
 As previously mentioned, multiple anthelmintic drugs are available for livestock 
producers on the market today. In 2012, Merial released a new product on the market, 
LongRange, which is an extended-release injectable form of eprinomectin (Forbes, 2013). Unlike 
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other anthelmintic drugs on the market, LongRange is effective for up to 150 d, which is much 
more convenient for producers than applications every 28 d. This extended release of 
eprinomectin in this product is because of the Theraphase technology that slowly releases the 
active ingredient over a longer period of time. The plasma concentrations of eprinomectin peak a 
few days after administration and then decline until about d 25 where they remain constant until 
approximately d 70. The second peak is seen around d 90 and again declines until about d 160 
when the product is then no longer in the animal’s body.  
As an injectable anthelmintic, administration of the product does not require specific 
tools to administer, as some topical and oral anthelmintic drugs require.  Additionally, when the 
drug is administered as an injectable, it has a higher efficacy than being administered as a pour-
on product, as weather or animal licking could impact efficacy of the pour-on products 
(Sutherland and Leathwick, 2011). Furthermore, the long-term release of the product makes it 
ideal to prevent parasite issues in herds throughout the grazing season without multiple 
administrations as it can stop the life cycle of the GIN and prevent resident adult worms from 
establishing in the host (Forbes, 2013).  
Extended-Release Eprinomectin and Fescue Toxicosis 
An experiment evaluating heifers treated with extended-release eprinomectin (ERE), a 
combination of moxidectin and oxfendazole (MO) and untreated controls (CON) was conducted 
to determine differences in heifer performance (Backes, 2016). Heifers in this experiment grazed 
endophyte-infected tall fescue, although, the impact on fescue toxicosis was not an objective. 
Only one parameter commonly associated with fescue toxicity was evaluated, hair coat score; 
although, no differences between treatments were reported. Fecal egg count were greater in CON 
heifers throughout the trial with the greatest difference being on d 84 with CON having 164 EPG 
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while treated cattle had 80 EPG and 6 EPG (MO and ERE, respectively). In addition, BW tended 
to be greater on d 84 for treated cattle compared to untreated cattle and the improvement 
continued from d 112 to 182. Moreover, ERE heifers tended to have greater BW on d 112 and 
had greater BW compared to MO heifers from d 140 to the end of the experiment (d 274). This 
improvement in BW also transitioned into an improvement in ADG and BCS at several time 
points throughout the experiment for treated heifers compared to CON heifers. It is important to 
note, that these cattle did have parasite differences, which could potentially impact the 
performance differences in this experiment. Furthermore, this experiment lacked replication of 
treatments as heifers grazed pastures separated by treatments with only one group per treatment.  
Not only did Backes (2016) report differences in performance, but also noted greater 
heifer cyclicity, estrous detection, natural service and overall pregnancy rates in treated heifers 
compared to CON heifers. Additionally, ERE tended to have greater overall pregnancy rates 
compared to MO heifers (89 vs. 71%, respectively). Further research should be conducted in this 
area to confirm these results without the confounding issues.  
In another experiment, Backes (2016) utilized spring-calving cows to determine 
differences in cows treated with extended-release eprinomectin (ERE), oral fenbendazole (OXF) 
and untreated controls (CON). Cattle grazed endophyte-infected tall fescue pastures, although 
determining impacts on fescue toxicity symptoms was not an objective. Hair coat score was the 
only parameter commonly associated with fescue toxicity that was evaluated. Hair coat score 
was greater for OXF cattle at d 91 compared to ERE and CON cattle, but it was not different at 
any other time point. Throughout the experiment, FEC were low (< 6 EPG), although, CON 
cattle had greater FEC at all time points compared to ERE and OXF cattle. There was a tendency 
for BW to be greater for CON cattle at d 14 compared to ERE and OXF cattle, although no 
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differences were reported at any other time. Cow BCS tended to be greater on d 14 and was 
greater on d 91 for OXF cattle compared to ERE cattle; however no differences were reported at 
any other time point. Pregnancy rate also tended to be greater for OXF cattle compared to ERE 
(81 vs. 61%, respectively). While this experiment had low FEC below the economic threshold, 
this experiment lacked replication of treatments as treatments grazed pastures in 2 groups per 
treatment and only 90 cattle in total were used in the experiment. Additional research in these 
areas should be conducted to determine differences without the confounding issues previously 
mentioned.  
A case study was conducted on extended-release eprinomectin in fall-calving beef cows 
to determine differences in cow performance compared to injectable ivermectin (Andresen et al., 
2018a). Treatments were administered in the fall, prior to the calving season, and both 
primiparous and multiparous cows were utilized. Based on the experimental design, ERE 
multiparous cows were heavier at experiment initiation than primiparous cows and ivermectin 
(CONV) multiparous cows. This greater BW continued throughout the experiment and ERE 
multiparous cows lost less BW over the duration of the experiment. However, there was no 
difference in pregnancy rates between treatments. Calves from ERE dams tended to have greater 
weaning weights compared to CONV calves and had greater adjusted weaning weights, as they 
were younger at weaning (Andresen et al., 2018a). It is important to note that this case study 
lacked replication of pastures, as well as, lacked animal numbers (n = 53 CONV and n = 66 
ERE), and FEC were not evaluated so it is difficult to compare this data to other research. 
Additionally, forage type was not mentioned so it is difficult to determine if these cattle were 
exposed to fescue toxicosis.  
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In a similar second experiment, fall-born beef heifers were utilized to determine 
differences on heifer performance between fall treatments of injectable ivermectin (CONV) and 
ERE (Andresen et al., 2018a). Greater BW was reported at final pregnancy check for ERE 
heifers compared to CONV; however, a year after initial deworming, ERE only tended to have 
greater BW to CONV heifers. Additionally, ADG was greater for ERE heifers for the duration of 
the experiment and pregnancy rates were greater for ERE heifers after artificial insemination and 
the overall breeding season. However, this experiment is also lacking replication of pastures, as 
well as lacking animal numbers (n = 33 CONV and n = 41 ERE), and FEC were not evaluated so 
it is difficult to compare this data to other research. Again, forage type was not mentioned, so 
exposure to fescue toxicity is unknown.  
In a larger study, 12 herds across seven states were utilized to determine impacts of ERE 
on production variables of beef cows and calves (Andresen et al., 2018b). Treatments included 
spring administration of ERE or injectable doramectin (DOR). Parasite infections were reported 
in this experiment, but remained low for both treatments (< 3 EPG) for the duration of the 
experiment. Cow BW and BCS was not different between treatments throughout the experiment. 
No differences were also reported for fly counts and pregnancy rates along with no differences in 
calf BW at birth, treatment, or weaning and ADG. However, fescue toxicosis was not an 
objective in this experiment so fescue toxicity parameters were not evaluated. Additionally, 
forage type was not mentioned so it is difficult to compare to other research.  
Only one experiment has evaluated extended-release eprinomectin impacts on fescue 
toxicosis (Volk et al., 2019). Volk et al. (2019) utilized growing heifers grazing E+ tall fescue 
with relatively low FEC (< 14 EPG). Treatments included a spring injection of extended-release 
eprinomectin (ERE) or a saline control (CON). Typical fescue parameters such as hair coat 
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score, respiration rate and serum prolactin were not different between treatments, although there 
was an improvement in BW and BCS in ERE cattle. In addition, pregnancy rates were improved 
in ERE cattle as well. No mechanism was suggested and more research is required to determine 
the cause of increased growth and reproductive performance.  
Research focusing on the effects of ERE on fescue toxicosis are lacking in beef cattle. 
Only one experiment has evaluated ERE on fescue toxicosis. Other research has been conducted 
utilizing ERE on beef heifers and cows; however, there have been issues in parasite infection 
differences as well as the lack of measuring fescue toxicosis parameters. In the future, the 
industry could potentially benefit from determining the effects of ERE on cattle grazing E+ tall 
fescue that are exhibiting symptoms of fescue toxicosis.  
CYTOCHROME P450 
Role in Ergot Alkaloid Metabolism  
Ergot alkaloids have been shown to cause numerous effects on cattle performance 
(Strickland et al., 2011).  Metabolism of ergot alkaloids in ruminants is a bit different than in 
other species as they have pregastric fermentation. An in vitro study conducted by Ayers et al. 
(2009) demonstrated that ergot alkaloid concentration increased over time in the rumen fluid 
which an in vivo study lead to increased absorption in the rumen. To alter the toxin in the body 
and eliminate them, ergot alkaloids go through a process called biotransformation which occurs 
through cytochrome P450 enzyme systems (Ball et al., 1992; Moubarak and Rosenkrans, 2000).   
 Cytochrome P450 enzymes (CYP) are located in the liver and are classified into families 
based on their function (Anzenbacher and Anzenbacherova, 2001). An example of a family 
would be denoted as CYP3 and then if the family needs to be divided into subfamilies, a letter is 
used to denote this classification (Anzenbacher and Anzenbacherova, 2001). For example, the 
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specific subfamily reported to biotransform ergot alkaloids is the CYP3A (Ball et al., 1992). 
Within this subfamily there are three genes: CYP3A4, CYP3A5 and CYP3A7. Two of these 
three (CYP3A4 and CYP3A5) are expressed in adults while CYP3A7 is expressed in fetal life 
(Strickland et al., 2011). Activity of CYP3A4 can vary greatly between individuals which is 
thought to be from DNA mutations and can vary up to 60-fold (Anzenbacher and 
Anzenbacherova, 2001; Strickland et al., 2011). This difference is also thought to potentially 
account for differences in individual’s susceptibility to ergot alkaloid intoxication (Strickland et 
al., 2011).  Ergot alkaloids can either activate or inhibit CYP activity which impacts the animal’s 
ability to handle the ergot alkaloids (Settivari et al., 2006). Additionally, as an individual ages, 
there is a decrease in drug metabolism which can also cause variability in CYP enzyme activity 
(Anzenbacher and Anzenbacherova, 2001). 
Drug-Drug Interactions 
 Not only are CYP enzymes known for metabolizing ergot alkaloids, but CYP enzymes 
are also known to be the main enzyme family that metabolizes therapeutic drugs (Cali et al., 
2009). The most active CYP in metabolizing drugs is CYP3A4 and because of this, it plays an 
important role in adverse drug-drug interactions (Cali et al., 2009; Strickland et al., 2011). 
However, CYP3A5 is less active in xenobiotic (drug) metabolism (Strickland et al., 2011). A 
drug interaction occurs when one of two scenarios occurs. If a drug inhibits CYP3A4 enzyme 
activity, it will slow the clearance of a co-administered drug which can lead to drug toxicity (Cali 
et al., 2009). Additionally, if the drug induces the expression of CYP3A4, then it will increase 
the clearance of a co-administered drug which leads to reduced efficacy (Cali et al., 2009). 
Moreover, interactions are not only observed with drugs but components of the diet can also take 
part (Anzenbacher and Anzenbacherova, 2001). The first of these scenarios is likely what is 
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occurring when ergot alkaloids are consumed, as they can inhibit and are metabolized by CYP 
enzymes, which leads to fescue toxicosis. The second scenario is an option for a way to 
potentially mitigate fescue toxicosis if a drug that could induce CYP3A4 expression was 
identified as it could increase the clearance of the ergot alkaloids.  
 Characteristics of having the ability to alter a concurrently administered drug include 
having a relatively long elimination half-life, the ability to bind to cytochrome P450 and having a 
high lipid solubility (Anadon, 1982). Ivermectin has been reported to be a potent inducer of liver 
enzymes and it has all three of the previously mentioned characteristics (Bohlen et al., 1995).  
Bohlen et al. (1995) reported no drug-to-drug interactions when comparing the use of ivermectin 
along with either antipyrine or erythromycin. The authors mentioned that the lack of effect could 
mean ivermectin does not impact biotransformation of drugs, but the authors cautioned drawing 
conclusions on all drugs from this (Bohlen et al., 1995). 
It is also important to note that the liver is the most important organ for xenobiotic 
metabolism and detoxification, which also makes it a main organ affected by fescue toxicosis 
(Settivari et al., 2006). Bacon and Hill (2013) summarized work that reported the liver is the first 
place ergopeptides are biotransformed and that drugs could impact this process. This work leads 
to the need for more research focusing on what drugs specifically could impact the process and 
potentially decrease impacts of the ergot alkaloids. Additionally, the impact on CYP in cattle that 
are experiencing fescue toxicosis is an area that needs more research. Analyzing CYP activity 
could be another method to identify cattle experiencing fescue toxicosis and could potentially be 
used to determine if mitigation strategies are effective.  
Previous beef cattle work with CYP450 
 Previous work with CYP enzymes has mainly been conducted with rats and humans. 
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However, some more recent studies have been developed to focus on the impacts of beef cattle. 
Moubarak and Rosenkrans (2000) designed an experiment to determine the role of CYP3A on 
the metabolism of ergotamine in beef liver. They compared the metabolite profile of CYP3A in 
beef cattle liver that had grazed E+ tall fescue to rat liver both of which were incubated with 
ergotamine. Results from this experiment were the first to show that CYP3A is present in beef 
cattle liver and also indicates it has a role metabolizing ergot alkaloids in beef cattle (Moubarak 
and Rosenkrans, 2000). From this experiment, more work was conducted to determine the 
differences in susceptibility to fescue toxicosis. 
 Sales et al. (2012) focused on identifying single-nucleotide polymorphisms (SNP) for 
cattle CYP3A28 and also the relationship this SNP has on cattle grazing different forages at 
different body condition scores. Results from this experiment documented that cow productivity 
is negatively impacted by low body condition and E+ tall fescue along with the genetic alteration 
of a cytosine to guanine at base 994 which is known as C994G in CYP3A28 (Sales et al., 2012). 
A similar study was published the following year, which focused on Brahman-influenced cattle 
and stated that SNP CYP3A28 was associated with cattle productivity (Sales et al., 2013). 
Further research is needed in this area to determine the impacts genetic selection could have on 
the industry.  
 Moubarak et al. (2012) tested the P450-Glo CYP3A4 assay kit to confirm if this assay is 
appropriate for determining the toxic levels of E+ tall fescue. Commercially available ergot 
alkaloids were used as the control. From this experiment, one can conclude that the P450-Glo 
assay will be useful when studying specific effects of each component of the E+ tall fescue on 
the detoxification methods in the liver (Moubarak et al., 2012). Rosenkrans Jr. and Ezell (2015) 
continued working with this assay and confirmed that urine from cattle grazing E+ tall fescue 
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could be used to see differences in CYP activity. This experiment also found that urine inhibition 
tended to be correlated with ADG of the steers. Additionally, steer genotype impacted inhibition 
of CYP450 activity in the urine with the least inhibition in heterozygous steers (Rosenkrans Jr. 
and Ezell, 2015). With more research, the P450-Glo assay may be useful in the future for 
identifying cattle that will be susceptible to ergot alkaloids. Furthermore, this assay may also be 
useful in determining the level of exposure cattle have had to fescue toxicosis. 
ANTHELMINTIC RESISTANCE IN CATTLE PARASITES 
Resistance in the United States  
The push for the industry to use anthelmintic drugs in cattle to improve animal 
performance appeared to be a step in the right direction at the time; however, good pasture 
management for parasites to prevent drug resistance was not as heavily focused on (Gasbarre et 
al., 2009; Sutherland and Leathwick, 2011). Sutherland and Leathwick (2011) defined 
anthelmintic resistance as having a greater number of GIN able to tolerate doses of the product 
than had previously been able to in a normal population of GIN. In small ruminants, GIN 
resistance is well documented in previous research to multiple classes of anthelmintic drugs 
(Waller, 1997); however, for cattle in the US, the first documented case has occurred in the past 
decade (Gasbarre et al., 2009). This resistance, specifically in macrocyclic lactones, has been 
seen and rapidly increasing in Cooperia spp. along with Haemoncus sp. (Gasbarre, 2014). 
According to the 2008 USDA National Animal Health Monitoring System’s survey, in the cow-
calf industry across the United States, Cooperia spp. is the most prevalent parasite (Stromberg et 
al., 2015). Stromberg et al. (2015) hypothesized that Cooperia spp. has greater resistance to 
macrocyclic lactones than in the past. Sutherland and Leathwick (2011) conducted a search on 
published literature to determine if resistance is increasing over time. Of the 145 documented 
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cases of GIN resistance in cattle parasites, majority of the cases occurred in the last five years 
prior to the search (Sutherland and Leathwick, 2011). An increase in resistance could be related 
to two factors: resistance is becoming a larger issue or that more producers and researchers are 
testing for resistance (Sutherland and Leathwick, 2011).  
Resistance Detection Methods 
 Determining resistance in cattle can be more difficult than in other small ruminants as 
cattle tend to have lower FEC overall compared to small ruminants (McArthur and Reinemeyer, 
2014). The most common method used to measure GIN resistance is the fecal egg reduction test 
(FERT; Coles et al., 1992; Gasbarre, 2014). Guidelines for the FERT were set by the World 
Association for the Advancement of Veterinary Parasitology in the early 1990s (Coles et al., 
1992). This process involves sampling prior to anthelmintic treatment and again 14-28 days post-
treatment depending upon the anthelmintic drug used. Groups of animals included in the study 
typically include a treated and an untreated group so that differences in GIN levels can be 
determined throughout the experiment (Taylor et al., 2002). The guidelines for sampling number 
in cattle are not clearly defined, but suggested to be around 10 animals (Coles et al., 1992) but 
for measuring resistance in a group, 20 animals is suggested to be the ideal sample size 
(Gasbarre, 2014). Resistance is present if the percentage of FERT is less than 95% (Sutherland 
and Leathwick, 2011) while others suggest 90% should be the threshold (Coles et al., 1992). 
Levecke et al. (2012) tested the detection limit of reduced efficacy of the tested anthelmintic for 
the FERT based on the method and number of FEC being excreted by the animal, sample size 
and sensitivity of the FEC method used. Overall results from this experiment concluded that with 
FEC methods having a sensitivity ≥ 5 EPG and sample sizes of < 15, unreliable results of the 
FERT would occur if the reduced-efficacy threshold was 95% (Levecke et al., 2012). However, 
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most combinations of sensitivity and sample size had reliable detection limits when the reduced 
efficacy-threshold was set at 90% (Levecke et al., 2012).  
  Another way to quantify anthelmintic resistance is to treat an infected host with the 
anthelmintic, and then kill the host to recover the GIN to be enumerated and classified by species 
(Gasbarre, 2014). This method allows for accurate quantification; however, it requires killing a 
large group of cattle for an experiment, which is not practical, so it is not commonly used 
(Gasbarre, 2014).  
Previous Research with Anthelmintic Resistance 
 As more reports of resistance have been documented in cattle, the interest in researching 
the level of resistance between different anthelmintic drugs has increased. Edmonds et al. (2010) 
conducted an experiment in California with heifer calves from multiple sources that had 
previously been administered with macrocyclic lactones several months prior to the study 
initiation. Cattle were processed and an initial FEC was recorded which was then used to stratify 
the heifers to their treatments. Anthelmintic treatment groups consisted of injectable ivermectin, 
injectable moxidectin, oral fenbendazole, oral oxfendazole, and saline. Fourteen days post-
treatment, cattle were necropsied for GIN infection to be determined. Reduced efficacy of all 
four anthelmintic drugs was detected as not all species of worms were reduced by >90%. Worm 
species that showed resistance included Cooperia spp. and O.Ostertagi (Edmonds et al., 2010).  
 Resistance was also measured in the southern United States by Walker et al. (2013) 
focusing on moxidectin or oxfendazole or a combination of the two given at separate times. Both 
heifers and steers were used in this FERT study. An addition of using coproculture procedure to 
classify the GIN remaining post-treatment was implemented so that no animals would need to be 
necropsied. Cattle given a combination of the two anthelmintic drugs at different times provided 
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greater parasite control and improved animal performance; however, it was noted that giving 
oxfendazole first provided better GIN control than if moxidectin was given fist. This study 
indicated signs of resistance of Cooperia spp. to moxidectin, but the authors noted that drought 
conditions were present during this experiment which could have impacted the results (Walker et 
al., 2013).  
 To determine the effectiveness of an extended-release eprinomectin (LongRange), 
Kunkle et al. (2013) conducted a study using 475 cattle across 7 locations in the United States. 
Control cattle were comingled with treated cattle throughout the experiment. Body weight, FEC, 
as well as a coproculture procedure was used to identify remaining GIN species post-treatment. 
All extended-release eprinomectin treated cattle had FEC reduced by ≥ 95% and the control 
cattle also had reduced FEC which could be related to the comingling of the cattle. Additionally, 
weight gain was significantly greater in eprinomectin treated cattle compared to control cattle 
(Kunkle et al., 2013). No resistance was seen in extended-release eprinomectin as an 
anthelmintic in this study; however, this experiment occurred shortly after extended-release 
eprinomectin was released to the market so more research on resistance should be conducted 
after extended-release eprinomectin has been used in the industry for a few years.  
Reducing Resistance 
 Resistance to anthelmintic drugs can be significantly more of a problem when the dose is 
under or over administered to the animal (Smith et al., 1999). To delay resistance, these drugs 
can be used in combination with another drug that has lower resistance (Gasbarre, 2014). For 
example, an injectable macrocyclic lactone co-administered with either benzimidazole or 
levamisole could control parasites that are resistant to macrocyclic lactones but not the latter two. 
Injectable slow-release anthelmintic that are effective over longer periods of time are able to 
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maintain optimal productivity, but others suggest that this will shorten the effectiveness of the 
anthelmintic by allowing for even more selective pressures on the parasite genome (Gasbarre, 
2014). However, mitigating the risk of resistance for long-acting products is essentially the same 
as shorter-acting products (Forbes, 2013).  
The first case of anthelmintic resistance in cattle was documented in macrocyclic lactones 
the past decade (Gasbarre et al., 2009).  It is important to note the heavy reliance on macrocyclic 
lactones in cattle production as they make up 88% of cattle anthelmintic sales (McArthur and 
Reinemeyer, 2014). One should also note, that implementing change in the use of anthelmintic 
drugs to reduce risk in the beef industry appears to be necessary, but, will require multiple 
discussions between producers, veterinarians, and researchers (McArthur and Reinemeyer, 
2014). By implementing a change sooner rather than later, the industry may be able to prevent 
more issues of resistance from occurring that could be a larger detriment to the industry.  
 
CONCLUSIONS 
 Tall fescue is productive in multiple environments and is still commonly grazed today by 
cattle across the United States. Fescue toxicosis is a concern to many cattle producers as it 
negatively impacts the industry greatly. Mitigation strategies to date have reduced symptoms of 
fescue toxicosis; however, they have not been cost effective or sustainable long-term. Some uses 
of anthelmintics in cattle grazing tall-fescue have shown improvements in cattle performance, 
with only previous experiment evaluating the impacts of extended-release eprinomectin.   
 In addition, macrocyclic lactone resistance has been reported in cattle parasites across the 
United States. Evaluations on parasite resistance to extended-release eprinomectin has not been 
widely reported at this time. Therefore, research in this thesis will evaluate parasite resistance to 
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extended-release eprinomectin on an operation after three years of use as well as discuss the 
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 The objective of this experiment was to determine if parasite resistance to extended-release 
eprinomectin (LongRange) is present in a cow-calf operation after 3 years of eprinomectin use 
and effects on heifer growth performance. Fall-born Angus × Simmental heifers [224 ± 22 d of 
age; 171.4 ± 17.8 kg initial body weight (BW)] were stratified by d -2 fecal egg count (FEC) and 
BW and were assigned to one of nine groups (7 heifers per group) using a stratified randomized 
design. Groups were then assigned to one of three treatments: extended-release eprinomectin 
(ERE; n = 3, extended-release eprinomectin and oxfendazole (COMBO; n = 3), or saline control 
(CON; n= 3). At experiment initiation, all heifers were administered treatments according to 
label instructions. All heifers grazed endophyte-infected tall fescue in groups and were 
supplemented daily with a 50:50 mix of distillers grains and soybean hulls (1.8 kg per heifer per 
d). Body weight and body condition score (BCS) were recorded 7 times throughout the 
experiment, while FEC and packed cell volume (PCV) were recorded 6 times throughout the 
experiment. A fecal egg reduction test (FERT) occurred on d 28. There was a treatment × time 
interaction (P < 0.01) for FEC. Fecal egg count was not different (P ≥ 0.51) at d -2, 28, 112, and 
167, but CON heifers had greater FEC (P < 0.01) than ERE and COMBO heifers on d 55. Also, 
at d 55 ERE heifers had greater FEC (P = 0.04) than COMBO heifers. At d 83 CON heifers had 
greater FEC (P < 0.01) than ERE and COMBO heifers. However, FEC was not different on d -2, 
28, 83, 112, or 167 (P ≥ 0.13) between ERE and COMBO heifers. Fecal egg count reduction for 
ERE and COMBO were above the 90% threshold (91% and 98% reduction, respectively). There 
42 
 
was no treatment × time interaction or treatment effect (P ≥ 0.14) for PCV. Additionally, there 
was a treatment × time interaction (P < 0.01) for BW. At d 83, ERE and COMBO tended (P = 
0.09) to have greater BW than CON heifers and on d 112 through d 168 ERE and COMBO 
heifers had greater BW (P < 0.01) than CON heifers. Likewise, there was a treatment × time 
interaction (P < 0.01) for BCS with COMBO having greater BCS (P < 0.01) compared to ERE 
and CON at d 55. On d 83, 112, 147, and 167, COMBO heifers had greater BCS (P < 0.01) 
compared to CON heifers. In addition, ERE had greater BCS (P < 0.01) compared to CON on d 
83, 112, and 167. Parasite resistance to extended-release eprinomectin was not present based on 
FERT, and ERE and COMBO heifers had greater growth performance compared to CON 
heifers.  
Keywords: anthelmintic resistance, beef heifer, extended-release eprinomectin 
 
INTRODUCTION 
Anthelmintic drug resistance was first documented in small ruminants in 1964 (Waller, 
1994), but more recently in 2003, resistance was reported in U.S. beef cattle (Gasbarre et al., 
2009). This resistance specifically to macrocyclic lactones in cattle has been noted and rapidly 
increasing in Cooperia spp. along with Haemonchus sp. (Gasbarre, 2014). According to the 2008 
National Animal Health Monitoring System’s survey, Cooperia spp. is the most prevalent 
parasite in the United States cow-calf industry, and could be increasing resistance to macrocyclic 
lactones (Stromberg et al., 2015). Additionally, parasite treatment and prevention is costly to the 
beef industry with $2.5 billion being spent on anthelmintic drugs each year (Williams and 
Loyacano, 2001). Internal parasites can impact cattle of all ages, but younger cattle are more 
43 
 
susceptible than mature cows (Miller, 1993). One of the most notable and costly impacts of 
clinical parasitism is decreased growth performance of growing cattle (Hawkins, 1993).  
Resistance to anthelmintic drugs can be significantly more problematic when the dose is 
under or over administered to the animal (Smith et al., 1999). To prevent resistance, a 
combination of anthelmintic classes can be used at the same time. For example, an injectable 
macrocyclic lactone co-administered with either benzimidazole or levamisole could control 
parasites that are resistant to macrocyclic lactones but not the latter two (Gasbarre, 2014). 
Injectable extended-release anthelmintics that are effective over longer periods of time are able 
to maintain optimal productivity, but some suggest that this will shorten the effectiveness of the 
anthelmintic by allowing for even more selective pressures on the parasite genome (Gasbarre, 
2014). However, mitigating the risk of resistance for long-acting products is essentially the same 
as shorter-acting products (Forbes, 2013). An extended-release eprinomectin has been recently 
released to the market (Forbes, 2013), but research is limited on parasite resistance to this 
product. Edmonds et al. (2018), reported parasite resistance to extended-release eprinomectin; 
however, this was conducted in treatment groups with different initial FEC and was only 
evaluated at one location. Therefore, the objective of this experiment was to determine if parasite 
resistance [<90% fecal egg reduction test (FERT)] was present in an operation after three years 
of use of extended-release eprinomectin and to determine the corresponding impacts on heifer 
growth performance.  
MATERIALS AND METHODS 
Animals and Experimental Design 
The Institutional Animal Care and Use Committee of the University of Illinois approved 
the procedures used in this experiment (protocol 18092) and followed the guidelines 
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recommended in the Guide for the Care and Use of Agricultural Animal in Agricultural Research 
and Teaching (FASS, 2010).  
To determine if parasite resistance to extended-release eprinomectin (LongRange; 
Boehringer Ingleheim, Duluth, GA) is present in an operation after three years of use, 63 Angus 
× Simmental heifers [171.4 ± 17.8 kg initial body weight (BW); age = 224.2 ± 21.6 d; mean ± 
standard deviation] were utilized at the University of Illinois Dixon Springs Agricultural Center 
in Simpson, IL. Heifers were stratified by d -2 fecal egg count (FEC) and BW and were assigned 
to one of nine groups (7 heifers per group) using a stratified randomized design. Groups were 
then assigned to one of three treatments (3 groups per treatment): extended-release eprinomectin 
(ERE), extended-release eprinomectin and oxfendazole (Synanthic; Boehringer Ingleheim, 
Duluth, GA; COMBO), or saline control (CON). Extended-release eprinomectin and saline were 
subcutaneously injected at a rate of 1mL/50 kg of BW on d 0, while oxfendazole and water were 
given as an oral drench at a rate of 1mL/50kg of BW on d 0. Any cattle not receiving an 
extended-release eprinomectin injection received a saline injection, while cattle not receiving 
oxfendazole oral drench, received a water drench at the same dosage.  
Cattle rotationally grazed endophyte-infected tall fescue (‘Kentucky-31’; 84% infected; 
total ergot alkaloid concentration: June: 804 µg/L; July 199 µg/L; August: 350 µg/L; October: 
1169 µg/L) pastures and had free-choice to a mineral supplement (Southern FS Services, Marion, 
IL; 12% Ca, 9.5% P, 17% salt, 5.9% Mg, 1.15% K, 24 mg/kg Co, 31 mg/kg I, 3,000 mg/kg Fe, 
1,400 mg/kg Cu, 2,000 mg/kg Mn, 26.4 mg/kg Se, 4,000 mg/kg Zn, 550,000 IU/kg vitamin A, 
3,300 IU/kg vitamin D, 220 IU/kg Vitamin E, and 6,600 mg/kg chlortetracycline). Pastures were 
grazed for three years prior by cattle treated with extended-release eprinomectin. Pasture size 
was 2.63 ± 0.11 ha, with an average of 0.38 heifers/ha. Groups were rotated every 14 d. As 
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groups were rotated, available forage was quantified in the pastures heifers were rotated out of 
and the pasture they went to by using a falling plate meter (Jenquip, Fielding, New Zealand) to 
collect 12 random measurements. A minimum of 99 kg DM/ha was available to all groups 
throughout the study, with 291 kg DM/ha of forage available on average (Fig. 2.2). Heifers were 
also supplemented daily with a 50:50 mix of soybean hulls and distillers grains [20.6% crude 
protein (CP), 51.9% neutral detergent fiber (NDF), 31.3% acid detergent fiber (ADF), and 5.1% 
crude fat] at a rate of 1.8 kg per heifer per d. 
Sample Collection and Analytical Procedures 
Body weights were collected seven times throughout the experiment with full 2-d BW 
measurements collected and averaged at the beginning (d -1 and 0) and end of the experiment (d 
167 and 168). Throughout the experiment, 1-d full BW measurements were collected on d 28, 
55, 83, 112, and 147. Body condition scores (BCS) were collected concurrent with BW and were 
evaluated using a 1-9 scale [emaciated =1; obese = 9; as described by (Wagner et al., 1988)].  
Rectal fecal grab samples were collected on d -2, 28, 55, 83, 112, and 167 for 
determination of FEC per gram of feces using a modified version of the Modified Wisconsin 
flotation method described in Volk et al. (2019). Fecal egg reduction test (FERT) was performed 
on d 28 to determine percent reduction using the following formula: % reduction = [(untreated 
FEC - treated FEC)/ untreated FEC] × 100 (DeRouen et al., 2009). Coprocultures were 
performed on fecal samples collected on d -2, 28, and 112 at the University of Georgia. Fecal 
samples were composited by pasture and 3rd stage larvae were identified and enumerated 
(Agriculture, 1977). Up to one hundred infected larvae, if possible, were identified to genus for 
magnitude of population differences. 
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Blood samples were collected for plasma at six (d -1, 28, 55, 83, 112, and 167) time 
points during the experiment. Blood was collected via jugular venipuncture into one 10 mL 
plasma blood collection vacuum tube with K2 EDTA (Becton, Dickinson and Co., Franklin 
Lakes, NJ). Hematocrit [packed cell volume (PCV)] was determined using the micro-hematocrit 
procedure.  Heparinized 75 mm micro-hematocrit capillary tubes (Fisher Scientific Co., Cat. No. 
02-668-66) were filled 2/3 full with whole blood and sealed with Critoseal clay in duplicate. 
Samples were then centrifuged in an international micro-capillary centrifuge (Model MB; 
International Equipment Company, Boston, MA) for 10 minutes and read on a micro-hematocrit 
capillary tube reader (Oxford Labware, St. Louis, MO) to determine % PCV.  
Forage samples were collected by randomly clipping approximately 5 cm from the 
ground, from at least 12 different locations, within each pasture. Feed and forage samples were 
collected every two weeks throughout the experiment. Forage and feed samples were dried at 
55°C for a minimum of 3 d, ground through a 1 mm screen using a Wiley mill (Arthur H. 
Thomas, Philadelphia, PA). Forage samples were composited by group into 3 time periods and 
feed samples were composited for the entire experiment. Ground feed and forage were analyzed 
for NDF and ADF using an Ankom 200 Fiber Analyzer (Ankom Technology, Macedon, NY) as 
well as CP (Leco TruMac, LECO Corporation, St. Joseph, MI; Fig. 2.1). Feed samples were also 
analyzed for crude fat using an Ankom XT10 fat extractor (Ankom Technology, Macedon, NY). 
Total ergot alkaloid analysis of forages was conducted in a commercial laboratory (Agrinostics 
Limited, Co., Watkinsville, GA).  
Statistical Analysis 
A stratified randomized design was used and group served as the experimental unit. Body 
weight, BCS, PCV, FEC, and forage analysis were analyzed as repeated measures in the MIXED 
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procedure of SAS (SAS Inst. Inc., Cary, NC), with fixed effects of treatment, and time, and the 
interaction of treatment and time. Group nested within treatment was included as a random 
effect. The REPEATED statement was used to model the repeated measurements within animal 
for each variable and the heterogeneous autoregressive (1) covariance structure was used after 
considering the Log Likelihood. Fecal egg count residuals were not normally distributed, so FEC 
were transformed using the BoxCox procedure of SAS. Fecal egg counts were transformed using 
(FEC +1)-1.25. Untransformed least square means are reported for FEC. The SLICE statement 
was used to separate least square means when the interaction of treatment and time was 
significant (P ≤ 0.05). Significance was declared at P ≤ 0.05, and tendencies were declared from 
0.05 < P ≤ 0.10. Means reported in tables and figures are least squares means. 
RESULTS 
 There was a treatment × time interaction (P < 0.01; Table 2.1) for FEC. Fecal egg count 
was not different (P ≥ 0.51) on d -2, and d 28, but on d 55 CON heifers had greater FEC (P < 
0.01) than ERE and COMBO heifers. Also, at d 55 ERE heifers had greater FEC (P = 0.04) than 
COMBO heifers. At d 83 CON heifers had greater FEC (P < 0.01) than ERE and COMBO 
heifers. However, FEC was not different on d -2, 28, or 83 (P ≥ 0.13) between ERE and 
COMBO heifers. On d 112 and 167, FEC was not different (P ≥ 0.82) between treatments. There 
was no treatment × time interaction or treatment effect (P ≥ 0.14) for hematocrit. The FERT was 
above the threshold for both ERE and COMBO groups (>90%) at 28 d post-treatment (91% and 
98%, respectively; Fig. 2.3).  
On d -2, infective larvae were recovered by coproculture and recorded by treatment 
groups with 80, 101, and 76 larvae present for ERE, COMBO, and CON heifers, respectively. 
Cooperia was the primary species (63% ERE, 56% COMBO, and 59% CON; Fig. 2.4) and 
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Ostertagia was the second most prevalent (31% ERE, 37 % COMBO, and 34% CON). 
Haemonchus sp. represented a small portion of all infective larvae in all treatments (9% ERE, 
7% COMBO, and 10% CON). Only COMBO heifers had Oesophagostum species; however, this 
was a low percent (1%).   
Twenty-eight days post-treatment, after coproculture procedure, 25, 2, and 78 larvae were 
speciated for ERE, COMBO, and CON heifers, respectively. There were too few larvae from 
COMBO cattle to speciate. Cooperia spp. represented 44% of ERE larvae and 71% of CON 
larvae. Ostertagia represented 59% of the ERE larvae and 26% of the CON larvae. ERE cattle 
had no larvae from the Haemonchus sp. and Oesophagosum sp. Haemonchus sp represented 4% 
of CON larvae and Oesophagostum represented 2% of CON larvae.  
 After 112 d post-treatment, 36, 8 and 32 larvae were identified from ERE, COMBO, and 
CON cattle, respectively. Primarily Cooperia spp. was present (57% ERE, 81% COMBO, and 
55% CON), with the remaining species including Ostertagia (21% ERE, 6% COMBO, and 30% 
CON), Haemonochus sp. (18% ERE, 13% COMBO, 11% CON), and Oesophagostum (7% ERE, 
0% COMBO, 5% CON).  
 There was a treatment × time interaction (P < 0.01; Fig. 2.5) for BW. Heifer BW tended 
to be different (P = 0.09) at d 83 as COMBO and ERE heifers tended to have greater BW than 
CON heifers. At d 112, 147, and 167, ERE and COMBO heifers had greater BW (P < 0.01) than 
CON heifers. Although, BW was not different (P ≥ 0.41) between ERE and COMBO heifers at 
any time point. Additionally, there was a treatment × time interaction (P < 0.01) for BCS. Heifer 
BCS was different (P < 0.01) at d 55 as COMBO heifers tended to have greater BCS (P = 0.10) 
compared to ERE, and ERE heifers tended to have greater BCS (P = 0.10) compared to CON. At 
d 83 and 112, ERE and COMBO heifers had greater BCS (P < 0.01) compared to CON heifers, 
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but BCS was not different (P = 0.28) between treated heifers.  At d 147, COMBO heifers had 
greater BCS (P < 0.01) than ERE and CON heifers, but BCS was not different (P = 0.43) 
between ERE and CON. On d 167, ERE and COMBO heifers had greater BCS (P < 0.01) 
compared to CON heifers, but BCS was similar (P = 0.57) between ERE and COMBO.  
DISCUSSION 
In this experiment, a combination of extended-release eprinomectin and an oral 
oxfendazole was used to compare to treatment of only extended-release eprinomectin to 
determine if the combination provided greater efficacy against parasite infection. Prior to 
treatment, all cattle had a basal level of parasite infection. Twenty-eight days post-treatment, all 
cattle had decreased FEC. A reduction in FEC at 14, 32, and 61 d after the start of the experiment 
was noted in both untreated controls and treated cattle in Edmonds et al. (2018). The reduced 
FEC in treated cattle in this experiment is similar to previous literature for cattle treated with a 
macrocyclic lactone or benzimidazole (Gasbarre et al., 2009; Edmonds et al., 2010; Walker et al., 
2013; Backes, 2016). Cattle in this experiment were maintained in treatment-specific pastures to 
prevent cross-over effects. Moreover, at the start of the experiment the cattle were moved to new 
pastures. Previous research conducted on other pastures at this station reported low FEC (< 14 
EPG), so the pastures may not have been heavily contaminated with parasites. Additionally, the 
cattle in this experiment were kept in relatively low stocking densities (0.38 heifers/ha), which 
may have also impacted parasite infection on the pasture (Stromberg and Averbeck, 1999; 
Vercruysse and Claerebout, 2001). Furthermore, at this time, lush spring forage was available, 
and heifers had access to excess forage (minimum of 212.65 kg DM/ha available), so they did 
not have to graze close to the ground and fecal pats, which could have impacted parasite loads 
(Stromberg and Averbeck, 1999).  
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 It is important to note that cattle tend to have lower FEC compared to small ruminants 
which can make determining resistance more difficult (McArthur and Reinemeyer, 2014). 
Despite the low FEC, control cattle had increased FEC at d 55 and 83 compared to ERE and 
COMBO cattle. This is similar to results in previous literature with untreated cattle having 
greater FEC compared to cattle treated with an anthelmintic (Kunkle et al., 2013; Walker et al., 
2013; Backes, 2016; Edmonds et al., 2018).  
Efficacy of anthelmintics are commonly reported after a FERT which compares pre- and 
post-treatment FEC to determine the reduction in fecal eggs (Coles et al., 1992; Gasbarre, 2014). 
In this experiment, a threshold of 90% or greater reduction was used to determine if resistance 
was present based on previous literature (Coles et al., 1992). Both anthelmintic treatments in this 
experiment had > 90% reduction in parasite infection at 28 d post-treatment. This is similar to 
results found in Kunkle et al. (2013) when evaluating the use of extended-release eprinomectin 
after it was first released to the market. In another experiment, Edmonds et al. (2018) reported a 
71 % FERT for extended-release eprinomectin. The FERT equation was different than the one 
used in this experiment, in which they used [(control FEC at d 32 – extended-release 
eprinomectin FEC at d 32) / control FEC at d 32]. Prior to treatment, Edmonds et al. (2018) 
reported significantly lower FEC for the extended-release eprinomectin group compared to the 
saline control group and other treatment groups. To accurately compare these experiments, the 
reduction equation used in this current experiment was utilized on the data from Edmonds et al. 
(2018), and a 84% reduction was determined. Parasite resistance to extended-release 
eprinomectin was present at that location (Edmonds et al., 2018), but was not present in this 
current experiment. Other previous work has shown signs of resistance to macrocyclic lactones 
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such as ivermectin, eprinomectin and moxidectin (Gasbarre et al., 2009; Edmonds et al., 2010; 
Walker et al., 2013).  
Using a combination of two different classes of anthelmintic treatments did result in 
greater reduction in this experiment. Similarly, previous literature has shown increased 
reductions when using a combination of a macrocyclic lactone and benzimidazole at the same 
time in cattle (Edmonds et al., 2018) and in sheep (Bartley et al., 2004). Moreover, increased 
reductions were also reported when using two different classes of anthelmintics administered 73 
d apart (Walker et al., 2013).  
Prior to treatment, all treatments had several species of parasites. At 28 d post-treatment, 
treated cattle had reduced parasite species of Cooperia spp., Ostertagia, and Haemonchus sp. 
Cattle treated with both extended-release eprinomectin and oxfendazole showed no parasite 
species present in the coproculture data, while ERE cattle had some level of Cooperia spp. and 
Ostertagia present. This indicates that extended-release eprinomectin may not be as effective 
against Cooperia spp. and Ostertagia as a combination of anthelmintics. Cooperia spp. and 
Haemonchus sp. have been reported to be increasing resistance to macrocyclic lactones in the 
United States and around the world (Gasbarre, 2014). Ostertagia has been reported to show 
resistance, but it is less wide spread (Gasbarre, 2014).  
Walker et al. (2013) reported that cattle treated with moxidectin 73 d after treatment with 
oxfendazole had mostly Cooperia spp. and Ostertagia present. A small portion of the larvae was 
Haemonchus sp. 14 d after treatment with moxidectin (Walker et al., 2013). In cattle treated with 
moxidectin and then 73 d later treated with oxfendazole, no parasite species were present after 
coproculture (Walker et al., 2013). However, at 35 d post second treatment, all cattle had 
Cooperia spp. and Ostertagia present (Walker et al., 2013). It is important to note that both 
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anthelmintics utilized in Walker et al. (2013) were short-acting anthelmintics and were not 
expected to have long-term parasite control. Additionally, coproculture data was not reported 
prior to the first treatment in Walker et al. (2013), so initial parasite species are unknown. 
 Results from Gasbarre et al. (2009) reported presence of Cooperia spp. and Haemonchus 
sp. in cattle treated with pour-on eprinomectin. However, the data was collected from necropsy 
of a subset of the animals in the experiment, so it is unknown what the parasite species were 
prior to treatment (Gasbarre et al., 2009). Although this demonstrates that post-treatment, 
parasite resistance is present (Gasbarre et al., 2009). 
Coproculture data was discussed in Edmonds et al. (2018) from anthelmintic treatments 
of doramectin, a combination of doramectin and albendazole, extended-release eprinomectin and 
an untreated control. Primary species reported in control animals throughout the experiment 
included Cooperia spp. and Haemonchus sp. Although not all treatments were mentioned in 
coproculture data at each time point, at d 32, extended-release eprinomectin cattle had decreased 
levels of Ostertagia and Cooperia spp. 
Recovered larvae post-necropsy was reported in Edmonds et al. (2018) from anthelmintic 
treatments of doramectin, a combination of doramectin and albendazole, extended-release 
eprinomectin and an untreated control. Unfortunately, no samples were collected prior to 
treatment, although 118 d post-treatment, parasite levels were reported. Ostertagia was present 
in samples from extended-release eprinomectin calves, but at decreased levels compared to cattle 
treated with either doramectin, a combination of doramectin and albendazole, or a saline control. 
Cooperia spp. was present in similar level throughout all treatments, along with Haemonchus 
placei adults and late- L4. Although early L4 Haemonchus placei were reduced in extended-
release eprinomectin calves compared to all other treatments.  
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Another indicator of parasite infection is anemia, which can be measured by hematocrit. 
Hematocrit evaluates the oxygen carrying capacity of the blood of the animal and can also be an 
indicator of dehydration level of the animal (Craig, 1988; Nordenson, 2006). In this experiment, 
there was no difference in hematocrit between treatments.  
Although not monitored in this experiment, external parasites could have been different 
between treatments. Previous work with extended-release eprinomectin has noted improvements 
in fly control (Vesco et al., 2015; Trehal et al., 2017), but other studies have not reported 
differences (Andresen et al., 2018).  
Growth performance of growing animals is decreased by parasite infection (Hawkins, 
1993). Although, parasite level was low in this experiment (< 10 EPG) and well below the 
economic threshold of 200 EPG (Vercruysse and Claerebout, 2001), treated cattle had greater 
BW compared to CON cattle starting at d 83 and continued throughout the rest of the 
experiment. Body condition score was also improved in treated cattle compared to CON cattle. 
Similar results were reported in growing heifers treated with extended-release eprinomectin in 
Volk et al. (2019), although in that experiment, all cattle were treated with fenbendazole 14 d 
prior to the start of the experiment. Cattle in this current experiment were maintained in separate 
groups on pastures by treatment, thus forage quality and availability was evaluated to determine 
if there were differences between the treatment groups. Forage quality was not different between 
treatments at any time point for NDF, ADF, or CP content. Additionally, all groups had similar 
forage availability and likely did not impact the performance differences of these cattle. Previous 
literature has reported increased performance in treated cattle compared to untreated cattle; 
however, in those experiments, FEC levels were greater (Kunkle et al., 2013; Walker et al., 
2013; Backes, 2016). Therefore, in those experiments, performance differences were likely 
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driven by parasite infection (Kunkle et al., 2013; Walker et al., 2013; Backes, 2016). In this 
current experiment, parasite load was low and the authors hypothesize that it is unlikely that 
parasite load explain the observed difference in performance.  
Overall, based on the FERT (> 90%), parasite resistance was not present in an operation 
after three years of use of extended-release eprinomectin. Fecal egg count reduction 
demonstrated that using a combination of extended-release eprinomectin and oxfendazole 
reduced parasite species at a greater level than extended-release eprinomectin alone. 
Coproculture data indicated that Cooperia spp. and Ostertagia were the most prominent parasite 
species present. Fecal egg counts were low in all treatments throughout the experiment and 
treated cattle had greater growth performance compared to control cattle. 
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TABLE AND FIGURES 
 
Table 2.1 Influence of anthelmintic treatments on heifer fecal egg count and hematocrit over time   
 Treatment1  P-Value2 
Item ERE COMBO CON SEM Trt Time 
Trt × 
Time 
n 3 3 3     
Fecal egg count, eggs per gram3     0.01 <0.01 <0.01 
     d -2 10.0 9.9 9.9 - 0.97   
     d 28 0.6 0.1 0.9 - 0.51   
     d 55 1.4b 0.1c 10.6a - <0.01   
     d 83 0.5b 0.1b 4.3a - <0.01   
     d 112 0.1 0.0 2.9 - 0.82   
     d 167 0.6 0.4 0.5 - 0.87   
Hematocrit, % packed cell 
volume     0.14 <0.01 0.95 
     d -1 37.4 36.5 36.2 0.54    
     d 28 33.7 33.5 33.0 0.57    
     d 55 36.7 36.2 36.1 0.51    
     d 83 36.8 35.8 35.8 0.52    
     d 112 36.6 35.8 35.4 0.58    
     d 167 36.1 34.7 34.0 0.57    
a,b,c Treatment means with different superscript are different (P < 0.01). 
1Treatments are defined as ERE, heifers that received injectable eprinomectin and oral dose of 
water; COMBO, heifers that received injectable eprinomectin and oral dose of oxfendazole; CON, 
heifers received a sterilized saline solution injection and oral dose of water at initiation of 
experiment. All treatments were administered at a rate of 1 mL per 50 kg of body weight. 
2Abbreviations are defined as Treatment effect (Trt) and Treatment × time effect (Trt × Time). 
3 Fecal egg count least square means are from untransformed data while the p-values are 








Figure 2.1 Forage quality [percentage crude protein (CP), neutral detergent fiber (NDF), and 
acid detergent fiber (ADF of endophyte-infected fescue (Festuca arundinacea) pastures from 
June 2018 to November 2018. Samples were collected as cattle rotated pastures and were 
composited every six weeks. There was no treatment × time interaction or treatment effect (P ≤ 
0.12) for NDF, ADF, or CP content. There was a time effect (P < 0.01) as NDF and ADF 
increased for all treatments over time while CP decreased at the midpoint and then increased at 










































Figure 2.2 Forage availability of endophyte-infected fescue (Festuca arundinacea) pastures 
from June 2018 to November 2018. Samples were collected as cattle rotated every two weeks. 
There was no treatment × time interaction or treatment effect (P ≤ 0.11) for forage availability. 











































Figure 2.3 Fecal egg reduction test was determined on d 28 using the following formula: % 
reduction = [(untreated FEC - treated FEC)/ untreated FEC] × 100. Treatments are defined as 
ERE (n = 3), heifers that received injectable eprinomectin and oral dose of water and COMBO (n 
= 3), heifers that received injectable eprinomectin and oral dose of oxfendazole at initiation of 






















Figure 2.4 Influence of anthelmintics on heifer coproculture over time. Treatments are defined as ERE, 
heifers that received injectable eprinomectin and oral dose of water; COMBO, heifers that received 
injectable eprinomectin and oral dose of oxfendazole; CON, heifers received a sterilized saline solution 
injection and oral dose of water at initiation of experiment. All treatments were administered at a rate of 1 
mL per 50 kg of body weight. Days are defined as d post treatment. Species are reported as the number 
larvae of the total count from that date. The following FEC correspond to the FEC reported after the 
coproculture procedure: d -2: 80, 101, and 76 larvae from ERE, COMBO, and CON respectively; d 28: 
25, 2, and 78 larvae from ERE, COMBO, and CON respectively; d 112: 36, 8, and 32 larvae from ERE, 




















































Figure 2.5 Effect of anthelmintics on heifer body weight (BW) and body condition score (BCS). 
Control cattle (n = 3) received a sterilized saline solution, ERE cattle (n = 3) received injectable 
eprinomectin, and COMBO cattle (n = 3) received injectable eprinomectin and oral oxfendazole 
at initiation of experiment. All treatments were administered at a rate of 1 mL per 50 kg of body 
weight. Significance of slice p-values are represented as: P ≤ 0.05 defined by *, and tendencies 
from 0.05 < P ≤ 0.10 are defined as †. There was a treatment × time interaction (P < 0.01) for 
BW. On d 83 COMBO and ERE heifers tended (P = 0.09) to have greater BW than CON heifers 
and did have greater BW (P < 0.01) than CON heifers at d 112, 147 and 167. Additionally, there 
was a treatment × time interaction (P < 0.01) for BCS. On d 55, COMBO had greater BCS (P < 
0.01) than CON and tended (P = 0.10) to have greater BCS than ERE. Throughout the rest of the 
experiment, COMBO had greater BCS (P < 0.01) than CON heifers at d 83, 112, 147, and 167, 
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EVALUATION OF CYP450 ACTIVITY AND LIVER ENZYMES AS POTENTIAL 
MECHANISMS OF EXTENDED-RELEASE EPRINOMECTIN MITIGATING FESCUE 
TOXICITY IN BEEF HEIFERS GRAZING ENDOPHYTE-INFECTED TALL FESCUE 
 
ABSTRACT 
 The objective of this experiment was to evaluate CYP450 activity and liver enzymes as potential 
mechanisms of extended-release eprinomectin mitigating fescue toxicosis in beef heifers grazing 
endophyte-infected tall fescue. Fall-born Angus × Simmental heifers [42 heifers; 170.2 ± 20.0 kg 
initial body weight (BW); 222 ± 21 d of age] were stratified by d -2 fecal egg count (FEC) and 
BW and were assigned to one of six groups (7 heifers per group) using a stratified randomized 
design. Groups were then assigned to one of two treatments: extended-release eprinomectin 
(ERE; n = 3), or saline control (CON; n= 3). At experiment initiation, all heifers were 
administered treatments subcutaneously at a rate of 1mL per 50 kg of BW. All heifers grazed 
endophyte-infected tall fescue in groups and were supplemented daily with a 50:50 mix of 
distillers grains and soybean hulls (1.8 kg per heifer per d). Body weight (BW), body condition 
score (BCS), and hair coat score (HCS) were recorded 7 times throughout the experiment, while 
respiration rates (RR) and serum prolactin and liver profile analysis was conducted at 5 times. 
Urine was collected at d 55 for total ergot alkaloid analysis and percentage total CYP activity. 
There was a treatment × time interaction (P < 0.01) for BW as ERE heifers had greater BW (P ≤ 
0.03) compared to CON heifers beginning on d 112. Additionally, there was a treatment × time 
interaction (P = 0.02) for BCS as BCS tended to be greater (P ≤ 0.09) from d 28 to 55 and was 
greater (P < 0.01) from d 83 on for ERE heifers. There was a tendency for a treatment × time 
interaction (P = 0.07) for respiration rate. Furthermore, there was a treatment × time interaction 
for HCS, with CON having greater (P = 0.05) HCS at d 55 and tended to have greater (P = 0.09) 
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HCS at d 83. There was no treatment × time interaction or treatment effect (P ≥ 0.58) on serum 
prolactin concentration. Total urinary ergot alkaloids were similar (P = 0.62) between treatments, 
although ERE cattle tended (P = 0.06) to have greater total CYP3A4 activity. There was a 
treatment × time interaction (P = 0.04) for alkaline phosphatase (ALP) as ERE cattle tended (P = 
0.06) to have greater ALP on d 55; however, ALP was not different (P ≥ 0.15) at any other time 
point. Additionally, there was a treatment × time interaction (P = 0.02) for gamma-glutamyl 
transferase (GGT). ERE cattle had greater (P < 0.03) GGT on d 28 and 112, and tended to have 
greater (P = 0.07) GGT at d 83. There was no treatment by time interaction (P = 0.86) for total 
protein, although ERE tended to have greater (P = 0.07) total protein than control. Extended-
release eprinomectin improved heifer growth performance, HCS, and tended to improve RR. In 
addition, extended-release eprinomectin tended to increase total CYP450 activity, and increased 
several liver enzymes in heifer grazing endophyte-infected tall fescue.   
Keywords: beef heifers, cytochrome P450, extended-release eprinomectin, fescue toxicosis 
 
INTRODUCTION 
 Fescue toxicosis, caused by an ergot alkaloid producing endophyte in the tall fescue 
plant, negatively impacts beef cattle productivity and costs the industry an estimated $2 billion 
annually (Kallenbach, 2015; Klotz and Smith, 2015). Symptoms of fescue toxicosis include 
decreased weight gain, vasoconstriction which leads to increased respiration rate, rough hair 
coat, and decreased serum prolactin concentrations, along with poor animal growth and 
reproductive performance (Roberts and Andrae, 2004; Strickland et al., 2011). 
 Previous literature has reported increased weight gain of growing cattle grazing 
endophyte-infected tall fescue when treated with ivermectin, an anthelmintic (Ellis et al., 1989; 
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Bransby et al., 1993; Bransby et al., 1995). Ivermectin is only biologically active in the animal 
for 28 d, which makes it difficult to be considered as a fescue toxicity mitigation strategy. A new 
extended-release eprinomectin (ERE), also known as LongRange, has been released to the 
market and is biologically active for up to 150 d (Forbes, 2013). Since the release, ERE has been 
shown to improve heifer growth and reproductive performance; however these experiments did 
not evaluate the effects on fescue toxicosis (Kunkle et al., 2013; Backes et al., 2015; DeDonder 
et al., 2015; Backes, 2016). Additional work conducted by Volk et al. (2019), evaluated heifer 
performance when grazing endophyte-infected tall fescue and administered either ERE or a 
saline control. All cattle had relatively low fecal egg count (FEC; <14 eggs per gram), however, 
cattle treated with ERE had greater average daily gain (ADG), body weight (BW), and body 
condition score (BCS). In addition, heifers treated with ERE had greater pregnancy rate, but no 
differences were reported in typical fescue toxicosis symptoms. Although, no clear mechanism 
was identified for the improved performance in ERE treated cattle.   
 Ergot alkaloids are known to be biotransformed to be eliminated from the body by 
cytochrome P450 (CYP) enzymes in the liver (Ball et al., 1992; Moubarak and Rosenkrans, 
2000). Moreover, CYP enzymes are also involved in drug-drug interactions as well as drug-
toxicant interactions (Cali et al., 2009).  The influence of one drug or toxicant can either inhibit 
or activate the CYP enzymes allowing for the second drug or toxicant to either increase or 
decrease clearance (Cali et al., 2009). Previous literature has reported that CYP enzymes in cattle 
play a role in metabolizing ergot alkaloids (Moubarak and Rosenkrans, 2000) and that a genetic 
single-nucleotide polymorphism (SNP) can be related to the animal’s CYP activity. 
Additionally, Rosenkrans Jr. and Ezell (2015) reported that urine from steers heterozygous for 
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the SNP had decreased inhibition on CYP activity and that this inhibition tended to be correlated 
with ADG of the steers.  
 Another factor impacted by fescue toxicosis, is cattle liver function. Previous reviews 
have noted reduced liver enzyme levels in cattle experiencing toxicity (Thompson and 
Stuedemann, 1993; Oliver, 1997). This reduced level of liver enzymes is suggested to possibly 
be causing the poor weight gain of these cattle (Thompson and Stuedemann, 1993; Oliver, 1997). 
Although, further mechanisms have not been addressed. Previous literature has not determined if 
the CYP mechanism and liver enzyme activity is affecting animal performance when extended-
release eprinomectin is administered. Therefore, the objective of this experiment was to evaluate 
CYP450 activity and liver enzymes as potential mechanisms of extended-release eprinomectin 
mitigating fescue toxicity in beef heifers grazing endophyte-infected tall fescue.  
 
MATERIALS AND METHODS 
Animals and Experimental Design 
The Institutional Animal Care and Use Committee of the University of Illinois approved 
the procedures used in this experiment (protocol 18092) and followed the guidelines 
recommended in the Guide for the Care and Use of Agricultural Animal in Agricultural Research 
and Teaching (FASS, 2010).  
To evaluate CYP450 activity and liver enzymes as potential mechanism of extended-
release eprinomectin (LongRange; Boehringer Ingleheim, Duluth, GA) on fall-born beef heifers 
experiencing fescue toxicity, 42 Angus × Simmental heifers [170.2 ± 20.0 kg initial body weight 
(BW); age = 222.2 ± 21.4 d; mean ± standard deviation] were utilized at the University of 
Illinois Dixon Springs Agricultural Center in Simpson, IL. Heifers were stratified by d -2 fecal 
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egg count (FEC) and BW and were assigned one of six groups (7 heifers per group) using a 
stratified randomized design. Groups were then assigned to one of two treatments (n = 3): 
extended-release eprinomectin (ERE), or saline control (CON). All treatments were 
administered subcutaneously on d 0 at a rate of 1 mL/50 kg of BW. Any cattle not receiving an 
extended-release eprinomectin injection received a saline injection at the same dosage. Cattle 
rotationally grazed endophyte-infected tall fescue (‘Kentucky-31’; 84% infected; total ergot 
alkaloid concentrations June: 459 ppb ERE, 340 ppb CON; July 143 ppb ERE, 364 ppb CON; 
August: 608 ppb ERE, 145ppb CON; Oct: 1156 ppb ERE, 1242 ppb CON) pastures and had 
free-choice to a mineral supplement (Southern FS Services, Marion, IL; 12% Ca, 9.5% P, 17% 
salt, 5.9% Mg, 1.15% K, 24 mg/kg Co, 31 mg/kg I, 3,000 mg/kg Fe, 1,400 mg/kg Cu, 2,000 
mg/kg Mn, 26.4 mg/kg Se, 4,000 mg/kg Zn, 550,000 IU/kg vitamin A, 3,300 IU/kg vitamin D, 
220 IU/kg Vitamin E, and 6,600 mg/kg chlortetracycline). Pasture size was 2.64 ± 0.13 ha, with 
an average of 0.38 heifers/ha. Groups were rotated every 14 d. As groups were rotated, available 
forage was quantified in the pastures heifers were rotated out of and the pasture they went to by 
using a falling plate meter (Jenquip, Fielding, New Zealand) to collect 12 random measurements. 
A minimum of 132 kg DM/ha was available to all groups throughout the study, with 294 ± 89 kg 
DM/ha of forage available on average (Fig. 3.2). Heifers were also supplemented daily with a 
50:50 mix of soybean hulls and distillers grains [(20.6% crude protein (CP), 51.9% neutral 
detergent fiber (NDF), 31.3% acid detergent fiber (ADF), and 5.1% crude fat] at a rate of 1.8 kg 
per heifer per d. 
Sample Collection and Analytical Procedures 
Body weights were collected seven times throughout the experiment with full 2-d BW 
measurements collected and averaged at the beginning (d -1 and 0) and end of the experiment (d 
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167 and 168). Throughout the experiment, 1-d full BW measurements were collected on d 28, 
55, 83, 112, and 147. Body condition scores (BCS) were collected concurrent with BW and were 
evaluated using a 1-9 scale [emaciated =1; obese = 9; as described by (Wagner et al., 1988)]. 
Hair coat scores (HCS; 1 to 5, in which 1= slick, short coat and 5 = unshed, full winter coat) 
were evaluated and recorded on d -1, 28, 55, 83, 112, 147, and 167. Additionally, respiration 
rates (RR) were evaluated on d 1, 29, 57, 85, and 113 in the afternoon. To determine respiration 
rates, two individuals simultaneously counted the number of breaths per heifer in 15 seconds. 
The two observations were then averaged and multiplied by four to determine breaths per 
minute. 
Blood samples were collected for serum at five (d -1, 28, 55, 83, and 112) time points and 
plasma at one time point (d 167), during the experiment. Blood was collected via jugular 
venipuncture into one 10 mL serum blood collection vacuum tube (Becton, Dickinson and Co., 
Franklin Lakes, NJ) and one 10 mL plasma blood collection vacuum tube with K2 EDTA 
(Becton, Dickinson and Co., Franklin Lakes, NJ). Blood in the serum tube was allowed to clot at 
room temperature before being centrifuged at 1,300 × g for 20 min at 5° C. Serum was stored at -
20° C for subsequent prolactin and liver profile analysis. Serum was pooled by group and was 
analyzed for prolactin concentration via a radioimmunoassay (Bernard et al., 1993). The intra 
assay CV was 5.9% and the inter assay CV was 7.6%. Serum liver profile was pooled by group 
and analyzed in a Beckman Coulter AU680 Chemistry Analyzer (Beckman Coulter, Brea, CA) at 
the University of  Illinois Veterinary Clinical Pathology Lab. Parameters included in the liver 
profile were alkaline phosphatase (ALP), aspartate aminotransferase (AST), gamma-glutamyl 
transferase (GGT), cholesterol, glucose, creatine kinase (CK), blood urea nitrogen (BUN), total 
protein, and triglycerides. The blood in the plasma tube was kept on ice and were processed 
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within 24 h. Whole blood was used to isolate DNA in a procedure similar to Sales et al. (2012) to 
genotype all cattle at CYP3A28 single nucleotide polymorphism (SNP). Genotypes at SNP site 
C994G were homozygous cytosine (CC), homozygous guanine (GG), and heterozygous (CG). 
As not all genotypes were equally represented in both treatments (ERE: CG = 13 animals, GG = 
8 animals; CON: CG = 8 animals, GG = 10 animals, CC = 3 animals), only cattle that were GG 
or CG were included for luminescence data.  
On d 55, urine samples were collected from ERE and CON heifers. Approximately 50 
mL of fresh urine was collected mid-stream when the animals were in the alley and chute. Urine 
samples were stored at -20° C for subsequent ergot alkaloid analysis. Total ergot alkaloids were 
determined in a commercial laboratory (Agrinostics Limited, Co., Watkinsville, GA).  
Enzyme activity for CYP450 was evaluated on urine samples using the Promega P450-
Glo Assay (product # V9920; Cali et al., 2009) following instructions in the kit. CYP3A4, 
specifically, was evaluated in this kit as it is known to biotransform ergot alkaloids and is a 
family in the CYP450 enzyme system (Ball et al., 1992). First, 12.5 µL of sample was added in 
triplicate to a 96-well plate (Corning Inc., Kennebunk, ME) along with 12.5 µL of CYP3A4 
solution, and incubated at room temperature for 10 min. The reaction was then initiated by 
adding 25 µL of NADPH regeneration system and incubated for 10 min at room temperature. 
Next, 50µL of luciferin detection reagent was then add to each well and incubated at room 
temperature for 20 min. CYP3A4 luminescence was then recorded with a luminometer (Synergy 
HT; BioTek Instruments Inc., Winooski, VT) using no filters and an integration time of 1 s/well. 
CYP3A4 luminescence was recorded in relative light units (RLU) and is reported as percentage 
of total activity. This was calculated using the following equation for each plate: {[(sample RLU 
– average negative control RLU)/ (average positive control RLU)] * 100}.  
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Forage samples were collected by randomly clipping approximately 5 cm from the 
ground, from at least 12 different locations, within the pasture. Feed and forage samples were 
collected every two weeks throughout the experiment. Forage samples were dried at 55°C for a 
minimum of 3 d, ground through a 1 mm screen using a Wiley mill (Arthur H. Thomas, 
Philadelphia, PA), and were composited for all six groups. Forage samples were composited by 
group into 3 time periods and feed samples were composited for the entire experiment. Ground 
feed and forage were analyzed for NDF and ADF using an Ankom 200 Fiber Analyzer (Ankom 
Technology, Macedon, NY) as well as CP (Leco TruMac, LECO Corporation, St. Joseph, MI) 
(Fig. 3.1). Feed samples were also analyzed for crude fat using an Ankom XT10 fat extractor 
(Ankom Technology, Macedon, NY). Total ergot alkaloid analysis of forages was conducted in a 
commercial laboratory (Agrinostics Limited, Co., Watkinsville, GA).  
Rectal fecal grab samples were collected on d -2, 28, 55, 83, 112, and 167 for 
determination of FEC per gram of feces using a modified version of the Modified Wisconsin 
flotation method. After collection, fecal samples were stored at 20°C until processed. Three 
grams of feces were mixed with 15 mL of a sodium nitrate solution (Feca-Med; VetOne, MWI 
Animal Health, Boise, ID) and strained into a 15 mL polypropylene conical tube (Corning; 
Corning, NY). Samples were then centrifuged for 7 minutes at 725 × g. After centrifugation, 
tubes were filled with the sodium nitrate solution to form a meniscus, and a cover glass slip 
(VWR VistaVision 18 × 18 mm; VWR International, Randor, PA) was placed onto the meniscus 
for 4 min. Cover slips were then removed and placed directly onto a microscope slide (VWR 
VistaVision 75 × 25 × 1 mm; VWR International, Randor, PA), which was scanned under a 
microscope to count the total number of eggs on the entire cover slip. Total number of eggs per 3 
grams of feces was recorded and then converted to eggs per gram (EPG) of feces for statistical 
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analysis. All cattle had low FEC throughout the duration of the experiment [< 11 eggs per gram 
(EPG)]. 
Statistical Analysis 
A stratified randomized design was used and group served as the experimental unit. Body 
weight, BCS, HCS, RR, average daily gain (ADG), serum prolactin concentration, forage 
analysis, and liver profile parameters were analyzed as repeated measures in the MIXED 
procedure of SAS (SAS Inst. Inc., Cary, NC), with fixed effects of treatment and time, and the 
interaction of treatment and time. Group nested within treatment was included as a random 
effect. The REPEATED statement was used to model the repeated measurements within animal 
for each variable and the heterogeneous autoregressive (1) covariance structure was used for 
BW, BCS, HCS, RR, ADG, serum prolactin concentration, and forage analysis after considering 
the Log Likelihood. The compound symmetry covariance structure was used for all liver profile 
parameters after considering the Log Likelihood. Day -1 values were used as a covariate for 
alkaline phosphatase, cholesterol, and GGT analysis. Glucose, AST, and CK residuals were not 
normally distributed, so these parameters was transformed using the BoxCox procedure of SAS. 
Glucose was transformed using (Glucose)-1.25, AST was transformed using (AST)-2.75, and CK 
was transformed using (CK)-1.75. Untransformed least square means are reported for glucose, 
AST, and CK.  The SLICE statement was used to separate least square means when the 
interaction of treatment and date was significant (P ≤ 0.05). The MIXED procedure of SAS was 
also used to analyze urinary ergot alkaloids with fixed effect of treatment. The MIXED 
procedure of SAS was also used to analyze CYP3A4 luminescence with fixed effects of 
treatment, genotype, and the interaction of treatment and genotype. Group nested within 
treatment was included as a random effect for both urinary ergot alkaloids and CPY3A4 
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luminescence. Significance was declared at P ≤ 0.05, and tendencies were declared from 0.05 < 
P ≤ 0.10. Means reported in tables and figures are least squares means. 
RESULTS 
There was no treatment × time interaction or treatment effect (P ≥ 0.14; Fig 3.1 and 3.2) 
for NDF or CP content of the forage along with forage availability. There tended to be a 
treatment × time interaction (P = 0.08) for ADF; however, when sliced by time, there was no 
differences (P ≥ 0.21). Additionally, there was no treatment effect (P = 0.11) for NDF, ADF, CP, 
or forage availability. Over time, NDF and ADF increased (P ≤ 0.03) in both treatments while 
forage availability fluctuated over time (P < 0.01) with the least forage available in August. 
However, there was no time effect (P = 0.18) for CP content. 
There was a treatment × time interaction (P < 0.01; Fig 3.3) for BW. Heifer BW was 
greater (P ≤ 0.03) for ERE at d 112, 146, and 168 than CON. Additionally, there was a treatment 
× time interaction (P = 0.02) for BCS. On d 28 and 55, ERE heifers tended (P ≤ 0.09) to have 
greater BCS compared to CON heifers. At d 83 and 112, ERE heifers had greater BCS (P < 0.01) 
compared to CON heifers.  At d 147, BCS was not different (P = 0.43) between treatments, but 
at d 167 ERE heifers had greater BCS (P < 0.01) compared to CON heifers.  
 Likewise, there was a treatment × time interaction (P = 0.05; Table 3.1) for ADG. From d 
0 - 55, and d 55 - 112 ERE heifers had greater (P ≤ 0.01) ADG compared to CON heifers. 
Although, from d 112-168, ADG was not different (P = 0.22) between treatments. There was a 
tendency for a treatment × time interaction (P = 0.07) for respiration rate; however, there was no 
treatment effect (P = 0.49). Furthermore, there was a treatment × time interaction for hair coat 
score. On d 55 CON heifers had greater (P = 0.05) HCS and on d 83 tended to have greater (P = 
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0.09) HCS compared to ERE heifers. However, there was no difference (P ≥ 0.12) in HCS at any 
other time point.  
 There was no treatment × time interaction or treatment effect (P ≥ 0.58) on serum 
prolactin concentration. Over time, serum prolactin concentration decreased (P < 0.01) in both 
treatments. Total urinary ergot alkaloids on d 55 was not different between treatments (P = 0.62; 
Table 3.2). Interestingly, CYP3A4 luminescence on a percentage of total activity tended to be 
greater (P = 0.06) for ERE compared to CON.  
 There was a treatment × time interaction (P = 0.04; Table 3.3) for ALP. On d 55, ALP 
tended (P = 0.06) to be greater in ERE compared to CON cattle; however, ALP was not different 
(P ≥ 0.15) between treatments at any other time point. Additionally, there was a treatment × time 
interaction (P = 0.02) for GGT. On d 28 and 112, GGT was greater (P < 0.03) for ERE cattle 
compared to CON, and tended to be greater at d 83 (P = 0.07) for ERE cattle. There was no 
treatment × time interaction or treatment effect (P ≥ 0.18) on AST, cholesterol, and glucose. 
Over time, AST concentration decreased (P < 0.01) in both treatments, while cholesterol 
increased (P < 0.01) until d 83 and then decreased on d 112.  
There was no treatment × time interaction effect (P ≥ 0.59; Table 3.4) on CK, BUN, total 
protein, or serum triglycerides and no treatment effect (P ≥ 0.39) on CK, BUN and serum 
triglycerides. There was a time effect for CK with values decreasing over time, with the only 
exception being an increase on d 55. There was a tendency for a treatment effect (P = 0.07) on 







The objective of this experiment was to evaluate CYP450 and liver enzymes as a 
potential mechanism of extended-release eprinomectin mitigating fescue toxicity of fall-born 
beef heifers grazing endophyte-infected tall fescue. Reduced growth performance is an impact of 
fescue toxicosis (Roberts and Andrae, 2004; Strickland et al., 2011). In this experiment, heifer 
BW was similar until d 112, in which ERE cattle had greater BW compared to CON. Improved 
BW continued until the end of the experiment (d 168). Additionally, BCS tended to be improved 
on d 28 and 55 and was greater for ERE on d 83, 112, and 167 compared to CON. Furthermore, 
ADG was improved from d 0 – 55 and d 55 – 112 for ERE cattle compared to CON, but ADG 
was similar from d 112 – 167. These results are similar to Volk et al. (2019) where heifers 
treated with extended-release eprinomectin had improved BW compared to control heifers 
beginning on d 55 and maintained this difference throughout the remainder of the experiment (d 
291). Similar patterns in improved BCS and ADG were noted as well (Volk et al., 2019). Other 
previous literature has reported that cattle grazing endophyte-infected tall fescue pastures and 
treated with ivermectin have improved BW gain compared to untreated controls (Ellis et al., 
1989; Bransby et al., 1993; Ivy et al., 1993; Bransby et al., 1995).  
Parasite loads have been known to have a negative impact on animal growth (Hawkins, 
1993). Fecal egg counts were monitored throughout this experiment and were low throughout the 
experiment (< 11 EPG). Parasite infection was reported well below the economic threshold (< 
200 EPG) in Bransby et al. (1993) and Ivy et al. (1993) but was not reported in other work (Ellis 
et al., 1989; Bransby et al., 1995). Moreover, FEC were reported to be low (< 14 EPG) in Volk et 
al. (2019) and likely were not impacting animal performance.  
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 Cattle in this experiment were maintained in separate groups grazing separate pastures by 
treatment to prevent cross-over effects from parasite burdens. Forage quality between treatments 
was compared to ensure forage quality was not impacting cattle performance between 
treatments. In this experiment, forage quality and availability was not different between 
treatments.  
 Increased respiration rate is another symptom of fescue toxicosis as vasoconstriction 
occurs from the endophyte-infected tall fescue (Finch, 1986). Respiration rate in this experiment 
tended to have a treatment by time interaction; however, there was no treatment effect. In 
addition, other indicators of fescue toxicosis, such as HCS and serum prolactin were analyzed. 
Hair coat score was improved in ERE heifers on d 55 and 83, but no differences in serum 
prolactin were noted. Volk et al. (2019) reported no differences in RR, HCS, or serum prolactin 
in heifers, treated with ERE or saline control. In a fescue toxicosis review, HCS was reported to 
increase when cattle were experiencing fescue toxicosis, while serum prolactin concentrations 
were decreased (Strickland et al., 2011).   
 Ergot alkaloids are toxins in the body and more than 90% of them are excreted in the 
urine (Stuedemann et al., 1998; Hill et al., 2000). Urinary ergot alkaloids can be measured to 
determine toxicity level on an animal basis to provide more accurate results than just analyzing 
pasture level (Hill et al., 2000). Additionally, urinary ergot alkaloids have been reported to 
possibly have a cause and effect relationship with animal performance (Hill et al., 2000).  In this 
current experiment, urinary ergot alkaloid concentration was similar to other work with cattle 
grazing endophyte-infected tall fescue (Hill et al., 2000); however, no differences were reported 
on d 55. Urinary ergot alkaloids were not analyzed in previous work focusing on both 
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anthelmintics and fescue toxicosis (Ellis et al., 1989; Bransby et al., 1993; Ivy et al., 1993; 
Bransby et al., 1995; Volk et al., 2019).  
 CYP450 enzymes are found in the liver and can be classified by their function into 
families (Anzenbacher and Anzenbacherova, 2001). Ergot alkaloids are reported to be 
biotransformed by CYP3A enzymes with the most prevalent being CYP3A4 (Ball et al., 1992; 
Anzenbacher and Anzenbacherova, 2001; Strickland et al., 2011). Therefore, CYP3A4 activity 
was measured in this experiment, and tended to be greater for ERE cattle at d 55. Previous 
literature has not evaluated the effects of macrocyclic lactones on CYP3A4 activity in the urine 
of animals (Ellis et al., 1989; Bransby et al., 1993; Ivy et al., 1993; Bransby et al., 1995; Volk et 
al., 2019). Rosenkrans Jr. and Ezell (2015) analyzed urine from steers grazing endophyte-
infected tall fescue, and when luminescence was reported by genotype of the steers, steers that 
were heterozygous (CG) had greater activity. Considering CYP450 is involved in drug-toxicant 
metabolism, and can be observed interacting with components of the diet (Anzenbacher and 
Anzenbacherova, 2001), the authors propose that extended-release eprinomectin may be 
activating CYP450 and increasing clearance of ergot alkaloids. In this experiment, ergot alkaloid 
clearance was similar, but the trend for increased CYP450 activity, may explain the improved 
performance of cattle treated with extended-release eprinomectin.   
Another indicator of fescue toxicosis is related to reduced liver enzyme function and was 
speculated in a review paper to impact the poor growth performance (Oliver, 1997). The authors 
acknowledge that all cattle in this experiment were grazing endophyte-infected tall fescue and 
experiencing toxicity. However, the authors speculate that increased liver enzyme function could 
potentially be a mode of action for extended-release eprinomectin to elicit the increased growth 
performance noted in previous experiments.  
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All liver enzyme function values in the current experiment were reported in the normal 
range according to the University of Illinois Veterinary Diagnostic Lab for the following 
parameters: ALP: 8 – 179 U/L; GGT: 4 U/L - 28 U/L; AST: 17-137 U/L; cholesterol: 44 – 150 
mg/dL; glucose: 48-73 mg/dL; BUN: 5-19 mg/dL; total protein: 5.9-8.3 g/dL. Serum triglyceride 
levels were outside of the normal range (6-23 mg/dL) from d 55 – 112 and creatine kinase was 
outside of the normal range at d -1 (50-320 U/L). Cattle treated with extended-release 
eprinomectin had greater ALP, GGT, and total protein compared to CON heifers. In addition, 
AST, cholesterol, and creatine kinase was numerically increased in ERE heifers compared to 
CON. There were no differences in glucose, BUN and serum triglycerides between treatments.  
Reduced levels of ALP, cholesterol, and total protein have been noted in cattle grazing 
varieties of endophyte-infected tall fescue that elicited varying levels of performance; however 
no differences were reported in AST, glucose, BUN, serum triglycerides, and creatine kinase 
(Bond et al., 1984). In another experiment, ALP, GGT, AST, creatine kinase were reduced in 
cattle consuming endophyte-infected tall fescue seed compared to cattle not consuming the 
endophyte; although no difference was reported in BUN between treatments (Dougherty et al., 
1991).  
Thompson and Stuedemann (1993) noted in a review that increased circulating ALP 
activity is an indication of induced activity in the liver, bone or other tissues suggesting that ERE 
cattle may have had increased liver activity. In the review, Thompson and Stuedemann (1993) 
also noted reduced levels of cholesterol but did not comment on serum glucose levels. In another 
review paper, GGT, AST, cholesterol, BUN, total protein, serum triglycerides, and creatine 
kinase was reported to be reduced and glucose levels were increased when cattle grazed 
endophyte-infected tall fescue, but the reviewer referenced unpublished results (Oliver, 1997). 
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The reduced BUN was hypothesized to be related to mild dehydration (Oliver, 1997). Moreover, 
another experiment reported reduced levels of ALP, AST, and creatine kinase after consuming 
endophyte-infected tall fescue (Piper et al., 1991).  
 Overall, heifer BW, BCS, ADG, and HCS were improved in cattle treated with ERE 
when grazing endophyte-infected tall fescue. Some parameters from the liver profile suggested 
improved liver enzyme function of ERE cattle compared to CON, while other parameters 
showed no differences. In addition, CYP3A4 activity tended to be increased in ERE cattle 
compared to CON, although other symptoms of fescue toxicosis were not different between 
treatments. Extended-release eprinomectin tended to increase CYP450 activity and improved 
some liver enzymes in heifers when grazing endophyte-infected tall fescue.  
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TABLES AND FIGURES 
Table 3.1 Influence of extended-release injectable eprinomectin on heifer average daily gain, 
respiration rate, hair coat score, and serum prolactin concentration over time   
 Treatment1  P-Value2 
Item ERE CON SEM Trt Time 
Trt × 
Time 
n 3 3     
Average daily gain, kg/day    0.01 <0.01 0.05 
     d 0 - 55 1.16 0.94 0.030 <0.01   
     d 55 - 112 0.61 0.47 0.036 0.01   
     d 112 - 167 0.42 0.36 0.035 0.22   
Respiration rate, breaths per 
minute    0.49 <0.01 0.07 
     d 1 65.3 71.0 2.09    
     d 29 53.4 55.3 1.56    
     d 57 55.8 53.0 1.79    
     d 85 31.5 33.4 1.56    
     d 113 46.2 46.2 1.38    
Hair coat score3    0.23 <0.01 0.01 
     d -1 3.0 3.5 0.24 0.16   
     d 28 2.5 3.0 0.22 0.12   
     d 55 2.0 2.6 0.20 0.05   
     d 83 2.1 2.6 0.20 0.09   
     d 112 2.4 2.2 0.14 0.34   
     d 147 2.9 3.0 0.15 0.65   
     d 167 3.1 3.1 0.16 1.00   
Serum prolactin, ng/mL    0.83 <0.01 0.58 
     d -1 30.74 40.40 10.180    
     d 28 31.68 30.05 6.986    
     d 55 24.26 19.93 4.274    
     d 83 10.86 13.09 2.883    
     d 112 1.09 1.29 0.396    
1Treatments are defined as ERE, heifers that received injectable extended-release eprinomectin; 
CON, heifers received a sterilized saline solution injection at initiation of experiment. All treatments 
were administered subcutaneously at a rate of 1 mL per 50 kg of body weight. 
2Abbreviations are defined as Treatment effect (Trt) and Treatment × time effect (Trt × Time). 






Table 3.2 Influence of extended-release injectable eprinomectin on heifer total urinary ergot 
alkaloids and CYP3A4 luminescence 
 Treatment1  P-Value 
Item ERE CON SEM Treatment 
     n 3 3   
Total urinary ergot alkaloids, ng/mg of 
creatinine     
     d 55 70.7 63.5 9.44 0.62 
CYP3A4 luminescence, % total activity     
     d 55 18.58 12.56 2.31 0.06 
1Treatments are defined as ERE, heifers that received injectable extended-release eprinomectin; 
CON, heifers received a sterilized saline solution injection at initiation of experiment. All treatments 
were administered subcutaneously at a rate of 1 mL per 50 kg of body weight. P-values for CYP3A4 







Table 3.3 Influence of extended-release injectable eprinomectin on heifer alkaline phosphatase, 
aspartate aminotransferase, gamma-glutamyl transferase, cholesterol, and glucose over time   
 Treatment1  P-Value2 
Item ERE CON SEM Trt Time 
Trt × 
Time 
n 3 3     
Alkaline phosphatase3, U/L    0.32 < 0.01 0.04 
     d -1 78.7 75.3 8.92 -   
     d 28 121.4 99.9 8.92 0.17   
     d 55 128.4 97.6 8.92 0.06   
     d 83 113.1 90.6 8.92 0.15   
     d 112 72.7 69.3 8.92 0.82   
Aspartate aminotransferase4, U/L    0.18 < 0.01 0.89 
     d -1 71.3 62.7 -    
     d 28 61.0 56.0 -    
     d 55 64.0 61.0 -    
     d 83 58.3 56.3 -    
     d 112 56.7 54.3 -    
Gamma-glutamyl transferase,4, 
U/L    0.14 < 0.01 0.02 
     d -1 9.8 11.2 0.57 -   
     d 28 13.8 11.8 0.57 0.03   
     d 55 11.8 10.5 0.57 0.14   
     d 83 12.8 11.2 0.57 0.07   
     d 112 13.8 11.8 0.57 0.03   
Cholesterol3, mg/dL    0.22 < 0.01 0.39 
     d -1 66.1 62.9 5.08    
     d 28 76.5 69.9 5.08    
     d 55 82.8 67.5 5.08    
     d 83 83.1 70.2 5.08    
     d 112 69.5 55.2 5.08    
Glucose, mg/dL4    0.66 0.23 0.97 
     d -1 58.0 55.3 -    
     d 28 63.3 57.0 -    
     d 55 67.3 71.0 -    
     d 83 63.7 82.0 -    
     d 112 54.7 51.3 -    
1Treatments are defined as ERE, heifers that received injectable extended-release eprinomectin; 
CON, heifers received a sterilized saline solution injection at initiation of experiment. All treatments 
were administered subcutaneously at a rate of 1 mL per 50 kg of body weight. 
2Abbreviations are defined as Treatment effect (Trt) and Treatment × time effect (Trt × Time). 
3d -1 was included as a covariate for all analysis (Aspartate aminotransferase: P = 0.04; Cholesterol: 
P = 0.06; Gamma-glutamyl transferase: P = 0.10). 




Table 3.4 Influence of extended-release injectable eprinomectin on heifer creatine kinase, blood urea 
nitrogen, total protein, and serum triglycerides over time   
 Treatment1  P-Value2 
Item ERE CON SEM Trt Time 
Trt × 
Time 
n 3 3     
Creatine kinase3, U/L    0.39 < 0.01 0.59 
     d -1 332.3 323.0 -    
     d 28 211.7 183.7 -    
     d 55 236.7 241.7 -    
     d 83 207.3 158.7 -    
     d 112 141.0 133.0 -    
Blood urea nitrogen, mg/dL    0.72 < 0.01 0.72 
     d -1 16.7 16.7 1.06    
     d 28 15.3 15.3 1.06    
     d 55 15.7 17.3 1.06    
     d 83 13.7 14.0 1.06    
     d 112 14.7 15.0 1.06    
Total protein, g/dL    0.07 0.49 0.86 
     d -1 6.50 6.37 0.171    
     d 28 6.70 6.47 0.171    
     d 55 6.63 6.40 0.171    
     d 83 6.57 6.27 0.171    
     d 112 6.53 6.03 0.171    
Serum triglycerides, mg/dL    0.50 < 0.01 0.90 
     d -1 24.3 22.3 1.59    
     d 28 22.0 22.0 2.08    
     d 55 27.3 25.3 2.50    
     d 83 34.7 32.0 3.74    
     d 112 30.0 27.7 2.21    
1Treatments are defined as ERE, heifers that received injectable extended-release eprinomectin; 
CON, heifers received a sterilized saline solution injection at initiation of experiment. All treatments 
were administered subcutaneously at a rate of 1 mL per 50 kg of body weight. 
2Abbreviations are defined as Treatment effect (Trt) and Treatment × time effect (Trt × Time). 






Figure 3.1 Forage quality [percentage crude protein (CP), neutral detergent fiber (NDF), and 
acid detergent fiber (ADF)] of endophyte-infected fescue (Festuca arundinacea) pastures from 
June 2018 to November 2018. Samples were collected as cattle rotated pastures and were 
composited every six weeks. There was no treatment × time interaction or treatment effect (P ≥ 
0.14) on NDF or CP content of the forage. There tended to be a treatment × time interaction (P 
= 0.08) for ADF; however, when sliced by time, there was no differences (P ≥ 0.21). 
Additionally, there was no treatment effect (P = 0.32) on ADF. There was a time effect (P ≤ 














































Figure 3.2 Forage availability of endophyte-infected fescue (Festuca arundinacea) pastures 
from June 2018 to November 2018. Samples were collected as cattle rotated pastures every two 
weeks. There was no treatment × time interaction or treatment effect (P ≥ 0.11) on forage 


































Figure 3.3 Effect of an extended-release injectable eprinomectin (LongRange) on heifer body 
weight (BW) and body condition score (BCS). Control cattle (n = 3) received a sterilized saline 
solution and ERE cattle (n = 3) received injectable eprinomectin at initiation of experiment. All 
treatments were administered subcutaneously at a rate of 1 mL per 50 kg of body weight. 
Significance of slice p-values are represented as: P ≤ 0.05 defined by *, and tendencies from 
0.05 < P ≤ 0.10 are defined as †. There was a treatment × time interaction (P < 0.01) for BW. 
Heifer BW was different (P ≤ 0.03) at d 112, 146, and 168 as ERE heifers had greater BW 
compared to CON heifers. Additionally, there was a treatment × time interaction (P = 0.02) for 
BCS. Heifer BCS tended to be greater on d 28 and 55 (P ≤ 0.09) for ERE heifers compared to 
CON heifers. At d 83, 112, and 167,ERE heifers had greater BCS (P < 0.01) compared to CON 
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The use of anthelmintics in ruminants has led to parasite resistance in cattle. Two classes 
of anthelmintics can be used in combination  to limit the occurrence of resistance; however this 
strategy is not widely implemented in the beef industry. An extended-release eprinomectin was 
recently released to the market and limited data has evaluated parasite resistance at this time. The 
current data determined that parasite resistance to extended-release eprinomectin was not present 
on an operation that has used it for three years. Treated heifers had improved growth 
performance compared to untreated heifers even when parasite levels were low. 
In addition, fescue toxicosis has negatively impacted the beef industry for many years. 
Multiple mitigation strategies have been attempted, although no one strategy has been adopted as 
an overall solution to this problem. Previous work has indicated that ivermectin, a macrocyclic 
lactone, may be effective at alleviating some negative impacts of toxicosis on growing cattle. 
Similar improvements in growth performance have been reported due to extended-release 
eprinomectin. In an attempt to understand the mechanism behind the growth performance 
differences, additional liver and fescue toxicity parameters were evaluated. In this current data, 
some fescue toxicity parameters were reduced and some liver enzyme functions were improved 
in cattle treated with extended-release eprinomectin. Furthermore, there was a trend for heifers 
treated with extended-release eprinomectin to have improved CYP3A4 total activity. These 
results suggest that extended-release eprinomectin may be working through the liver to improve 
cattle performance when grazing endophyte-infected tall fescue.  
